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ABSTRACT OF THE DISSERTATION 
 
The Mechanisms of  
Lipid and Bacterial Interactions  
with the Host Immune Response in Acne Vulgaris  
by 
Tran Hue Do 
Doctor of Philosophy in Molecular Biology 
University of California, Los Angeles, 2020 
Professor Robert L. Modlin, Chair 
 
Acne vulgaris is a great example to study the interaction among the environment, 
microbes, and host immune response. Acne vulgaris is a highly prevalent chronic inflammatory 
skin disease thought to be caused by increased in sebum secretion, bacterial colonization by 
the ubiquitous bacterium Cutibacterium acnes (C. acnes), and host inflammatory response. As a 
major factor implicated acne pathology, sebum and its composition, squalene, are unique to 
humans. Sebaceous lipids accumulate in the follicular duct are oxidized by C. acnes lipase 
leading to bacterial proliferation. The direct cause-and-effect relationship between the bacteria 
has been difficult to establish given that C. acnes is a ubiquitous bacterium and that there was 
no quantitative difference in the number of bacteria between subjects with and without acne. 
Recent genomic and phenotypic analyses on acne clinical samples revealed different 
phylotypes of C. acnes coexist in the pilosebaceous unit with other Cutibacterium spp. included 
C. granulosum and C. humerusii. Studies also showed strains phylotype IA1 are more abundant 
with the skin on acne patients (CA) and phylotype II are more associated with healthy skin (CH). 
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However, the mechanisms underlying the lipid and bacterial interaction to cause the onset of 
inflammation and subsequent development of acne are still not understood.  
This dissertation begins with a detailed analysis using single cell RNA-seq to 
deconstruct the genetic and molecular profiles of individual cells to study differences in lesional 
and non-lesional skin of acne patients. Particularly we were interested in changes within the 
same cell types to understand how normal skin becomes inflamed acne skin. We identified that 
a TREM2 macrophage subpopulation, expressing a lipid gene metabolism program, is 
associated with acne lesions. We further discovered that squalene induces TREM2+ 
macrophages in vitro to have enhanced phagocytosis but minimal antimicrobial activity against 
C. acnes. As a result, the squalene induced TREM2+ macrophage perpetuates inflammation 
linking the excess lipid production in acne to inflammation in acne.  
Next, we investigated clinical strains of C. acnes, CA and CH, to understand how the 
microbiome interact in acne lesions. These strains differ in their ability to trigger inflammation 
with CA induces higher pro-inflammatory cytokine secretion compared to CH in cell culture and 
mouse infection model. However, the virulence factor that accounts for the differences in 
immune response between CA and CH are still unknown. In this study, we showed that C. acnes 
activates the innate immune system through RNA species that are usually reserved for viral 
detection. Interestingly, RNA species from CA and CH have different bioanalyzer profiles and 
can trigger distinct immune response as seen with live bacteria. We also showed that CA RNA 
stimulate the immune response through a TLR-8/IL-18/IL-12p40 pathway. Our in vitro data 
correlates well with our scRNA-seq data showing the abundance of IFN-γ and TLR-8 in acne 
lesions. 
Taken together, the results enhanced our understanding of the impact of squalene, a 
sebum lipid, and resident microbes on the immunological functions of the skin. This work 
advanced our knowledge of the environment-microbe-host interplay occurring at the 
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pilosebaceous follicle and introduced a novel way of thinking about the mechanisms underlying 
the initiation and pathogenesis of acne vulgaris and inflammatory skin conditions.  
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CHAPTER 1 
 
INTRODUCTION 
 
The skin is the human largest organ and home to a vast microbial community, with 1010 
bacteria across the 1.8m2 of the skin surface (Grice, Kong et al. 2008). It serves a vital role as 
our body’s first line of defense against environment stimuli and potentially pathogenic microbes 
we encounter. The skin exists in a unique immunological state. It must respond to the 
environment, tolerate and avoid reacting to resident microbes under normal conditions while 
ready to defend against any invading pathogens. The ecology of the different organisms in the 
skin is highly influenced by the vastly different environments across the body (Grice and Segre 
2011, Byrd, Belkaid et al. 2018). It hosts diverse communities of microorganisms on and within 
the skin and its appendages. Under normal conditions, these resident microbes adapt their 
environment and exist without eliciting an inflammatory response (Byrd, Belkaid et al. 2018). 
These microbes also acclimate to various host immunological factors and behavior. On the 
other hand, cells in the skin are tasked with the unique challenge of harboring the microbes 
without inducing unwarranted inflammation. But at the time of an invading microbe or a 
commensal becomes pathogenic and outcompetes the other microflora, the resident cells must 
act quickly and efficiently to protect the host from invading microbes (O’Neill and Gallo 2018). Of 
course, this execution is not perfect. Sometimes, the activation of immune pathways is 
prolonged due to the continued presence of the stimuli or the immune system failed to dampen 
the inflammation process. This leads to unwarranted inflammation resulting irreversible host 
tissue damage (Holland and Jeremy 2005). Inflammation localized to the pilosebaceous unit is 
often the defining feature of acne vulgaris.  
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Acne vulgaris is a chronic inflammatory skin disease that affects more than 5 million 
Americans annually (Lim, Collins et al. 2017). In the U.S, acne is the most diagnosed skin 
condition as well as the most common condition seen by a dermatologist (Lim, Collins et al. 
2017). Most people experience acne during early adolescence, with boys are more likely be 
affected than girls, >95% versus 85%, respectively (Burton, Cunliffe et al. 1971). About 20% of 
young patients have moderate to severe acne that negatively affect their quality of life, more 
than 50% of patients continue to suffer with acne beyond their adolescent years (Karimkhani, 
Dellavalle et al. 2017, Thiboutot, Dreno et al. 2018). Patients are often (Ghodsi, Orawa et al. 
2009) concerned about the redness, pain, post-inflammatory hyperpigmentation, and scars that 
are associated with inflammation-induced damage (Thiboutot, Dreno et al. 2018). The effects of 
acne are not limited to the visible lesions on the skin but also affecting adolescents and young 
contributing significantly to their low self-esteem (Nguyen, Koo et al. 2016), anxiety, depression, 
and increased risk of suicide (Purvis, Robinson et al. 2006, Vallerand, Lewinson et al. 2018). 
Acne is estimated to lead to suicidal ideation in 7% of patients (Picardi, Mazzotti et al. 2006). 
The disease develops from the pilosebaceous unit of the skin, which consists of hair shaft, hair 
follicle, sebaceous gland, and erector pili muscle. These units are most dense on scalp, face, 
neck, and shoulder, followed by torso and limbs (Wertz 2009). Palms, soles, and top of the feet 
are the only regions without any pilosebaceous units. The sebaceous gland connects to the hair 
follicle by a short sebaceous duct, in which the sebum flows. These are different from 
sebaceous follicle, which are less abundant and are not associated with major hair follicle. Acne 
vulgaris is an interplay of altered sebum secretion, hyperproliferation of keratinocytes, bacterial 
colonization by Cutibacterium acnes (C. acnes), and activated host innate immunity (Holland 
and Jeremy 2005). Acne typically starts in early puberty with maturation of the androgen gland 
leading to increase in sebum production along with the appearance of pubic and axillary hair 
(Lucky 1998).  
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Sebum is secreted by the sebaceous gland and comprises of squalene, triglycerides, 
free fatty acids, wax ester, cholesterol, and cholesteryl ester. Sebum production can be 
activated by histamines, androgens, stress, and diet (Pelle, McCarthy et al. 2008, Zouboulis 
2009). Sebaceous glands functions as its own endocrine organ responding to corticotropin-
releasing hormone in times of stress mediating acerbation of acne (Zouboulis and Böhm 2004). 
They can also produce a variety of antimicrobial peptides, neuropeptides, and antibacterial 
lipids such as sapienic acid (Lovászi, Szegedi et al. 2017) . Increased sebum secretion from the 
pilosebaceous unit contributes to the pathogenesis of acne and likely triggers the inflammatory 
response that clinically present as comedones, papules, pustules, and nodules (Smith and 
Thiboutot 2008, Zouboulis, Jourdan et al. 2014, Lovaszi, Mattii et al. 2017). Acne generally 
occurs on areas with more sebaceous glands such as face, shoulders, upper chest, and back 
(Lovászi, Szegedi et al. 2017). Composition of the sebum also changes in acne patients with 
squalene representing a greater proportion of total sebaceous lipids with more than a 2-fold 
increase in production (Pappas, Johnsen et al. 2009). Mediated by leukotriene B4, squalene 
can stimulate keratinocyte proliferation and secretion of inflammatory responses (Alestas, 
Ganceviciene et al. 2006). Changes in sebum lipids either induce defective keratinocyte 
differentiation, leading to hyperkeratinization, or induce interleukin 1 (IL-1) secretion that leads 
to the formation of hyperkeratinization leading to comedone formation (Lovászi, Szegedi et al. 
2017). Although the onset of inflammation is still highly debated, once inflammation is 
established, inflammatory acne lesions are characterized by upregulation of matrix 
metalloproteinases (MMP), β-defensins 4, IL-8, and granulysin (Trivedi, Gilliland et al. 2006). 
NF-kB pathways are also activated in acne lesions upregulating IL-8,  IL-1β, and tumor necrosis 
factor (TNF) (Kang, Cho et al. 2005). Increased IL-8 attract inflammatory cells such as 
neutrophils and macrophages. IL-1β and TNF are known to upregulate ICAM-1 and VCAM-1, 
which are also increased on endothelial cells in inflammatory acne papules (Kang, Cho et al. 
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2005). IL-17A+ T cells and T helper 17 (Th17)-related cytokines are also present in acne lesions 
(Kelhala, Palatsi et al. 2014). Many of these pathways have been shown to be induced in the 
presence of C. acnes.  
C. acnes is a microaerophilic, Gram-positive bacterium that is ubiquitous on human skin, 
representing 90% of the skin total bacteria (Fitz-Gibbon, Tomida et al. 2013). C. acnes derives 
nutrients for growth from sebum. During puberty, the marked increase in C. acnes colonization 
correlate with the maturation of sebaceous glands (McGinley, Webster et al. 1980). C. acnes 
co-exists in acne lesions with many other species of bacteria (Whiting 1979, Bialecka, Mak et al. 
2005). C. acnes overgrowth is strongly related to the progression of acne vulgaris (Russell 
2000, Nakatsuji, Tang et al. 2011), However, a direct cause-effect relationship between the 
presence of C. acnes and acne vulgaris have difficult to prove given that the amount of C. acnes 
on the skin was similar between patients with acne and normal skin. A metagenomic analysis 
showed that the strain phylotypes were different between the two groups (Fitz-Gibbon, Tomida 
et al. 2013). Full-genome sequencing with SNP-based phylotyping in conjunction with ribotyping 
based on 16S rRNA (Fitz-Gibbon, Tomida et al. 2013, Tomida, Nguyen et al. 2013) revealed 
that phylotype based on tly and recA genes, IA1, and ribotype (RT) 4 are associated with acne. 
The acne-associated types (CA) were present in significant quantities in approximately 30–40% 
of patients with acne but rarely in individuals with healthy skin. Conversely, the phylotype II, RT 
6 subgroup was found to be 99% associated with healthy skin (CH) (Fitz-Gibbon, Tomida et al. 
2013). These strains also have different inflammatory potential: CA induces a pro-inflammatory, 
IFN-γ and IL-17 release while CH induces a more anti-inflammatory, IL-10 response (Yu, 
Champer et al. 2016). C. acnes triggers toll-like receptor 2 (TLR-2) activation leading NF-κB 
activation and release of TNF and IL-8 (Takeuchi, Hoshino et al. 1999, Kim, Ochoa et al. 2002). 
C. acnes also promotes Th1 and Th17 response with IFN-γ and IL-17A secretion by CD4+ T 
cells, discovered both in vitro and in acne lesions (Agak, Qin et al. 2014, Yu, Champer et al. 
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2016, Agak, Kao et al. 2018). C. acnes can also activate NOD-, LRR- and pyrin-containing 3 
(NLRP3) inflammasome resulting in IL-1β and IL-18 secretion (Kistowska, Gehrke et al. 2014, 
Li, Lin et al. 2019) as well as upregulate the expression of pro-inflammatory cytokines and 
antimicrobial peptide secretion in cultured sebocytes and keratinocytes (Graham, Farrar et al. 
2004, Sanford, O'Neill et al. 2019). 
There is a need to advance the understanding of acne pathophysiology to address the 
lack of new acne therapy. Topical treatments are effective in treating open and closed 
comedones with few inflammatory lesions. Benzoyl peroxide has antimicrobial activity against 
C. acnes in vitro, but it causes irritation, redness, and scaling at the concentrations required for 
topical therapy (Ozolins, Eady et al. 2004). These topical often work by application when applied 
to the whole area, but often comedones may not be readily visible. Topical retinoids work for 
both comedonal and inflammatory acne but are contraindicated in pregnant women, and all 
women of childbearing age must use effective contraception (Blasiak, Stamey et al. 2013). All 
topical retinoids induce local reactions and can increase skin sensitivity to ultraviolet light. 
Topical antibiotics, such as clindamycin, erythromycin, and tetracycline, are often used in 
combination therapy with either benzoyl peroxide or topical retinoids (Ozolins, Eady et al. 2004). 
However, efficacy of topical antibiotics might be declining with increased bacterial resistance. 
Systemic retinoids are effective but have multi-system side effects, including teratogenicity 
(Blasiak, Stamey et al. 2013). Oral antibiotic therapy is often inadequate because of systemic 
effects and a ~60% resistance rate in the target organism (Leyden, McGinley et al. 1975, Eady, 
Cove et al. 1989, Cooper 1998, Coates, Vyakrnam et al. 2002, Ross, Snelling et al. 2003). 
Combined oral contraceptive are effective for women doubling as acne treatment and birth 
control. However, the efficacy of oral contraceptive only works for some women and 
contraindicated in women with increased risk of thromboembolism (Arowojolu, Gallo et al. 
2012). Over the last several decades, there has been little progress and minimal research into 
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advancing treatment through a better fundamental understanding of the pathophysiology of 
acne. 
 Acne vulgaris is an excellent model to study the interaction among local environment, 
microbiome, and the immune response. New insights into host-microbe interactions and the 
composition of the acne microbiome now make it possible to significantly advance the 
understanding of acne pathophysiology. We began our studies with the question of what are the 
mechanisms underlying the onset of inflammation in acne? We hypothesized that changes in 
sebum production and the presence of distinct C. acnes phylotypes differentially trigger 
inflammation. New technology such as scRNA-seq is a key innovation towards defining at 
single-cell resolution the diverse cell types/states and pathways that drive complex biological 
systems. We first used scRNA-seq to define the cell types and immune circuits present in acne 
lesions. We also dissected the mechanisms that underlie the induction of pro-inflammatory in 
lesional and non-lesional skin of acne patients. We then were able to differentiate monocytes to 
a specialized population of macrophages that are like those found in the lesion to study their 
ability to regulate inflammation. Finally, we investigate how different strains of C. acnes with 
different inflammatory potential to trigger inflammation.  
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CHAPTER 2 
 
Single cell Transcriptomic Analyses Reveal TREM2 Macrophages as a Possible Lipid 
Sensor Modulating Inflammation in Acne Lesion 
 
Abstract 
The pathogenesis of acne involves the excess production of lipids by the sebaceous hair 
follicle, which is colonized by Cutibacterium acnes (C. acnes), resulting in a host inflammatory 
response. The mechanisms by which these lipids modulate distinct cell populations promoting 
inflammation at the site of the disease remain unclear. Here, we used scRNA-seq analysis to 
comprehensively map cell populations and their gene expression profiles in inflamed lesions 
and non-lesional skin from acne patients. We identified that a TREM2 macrophage 
subpopulation, expressing a lipid gene metabolism program as well as IL18, is associated with 
acne lesions. We further discovered that squalene, excessively secreted by the human 
pilosebaceous unit in acne, induces TREM2+ macrophages in vitro to have enhanced 
phagocytosis but no antimicrobial activity against C. acnes, yet secrete IL-18. Thus, the 
squalene induced TREM2+ macrophage perpetuates inflammation linking the excess lipid 
production in acne to inflammation in acne. The ability of squalene to induce TREM2+ 
macrophage differentiation may have important implications as a potential therapeutic target in 
acne vulgaris.  
 
Introduction 
Acne vulgaris is a highly prevalent skin inflammatory disease affecting more than 5 
million Americans annually (Lim, Collins et al. 2017) and imposing a significant psychologic 
burden associated with low self-esteem (Nguyen, Koo et al. 2016), anxiety, depression, and 
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suicidal ideation (Purvis, Robinson et al. 2006, Vallerand, Lewinson et al. 2018). The disease 
develops from an interplay of sebum secretion, bacterial colonization by the commensal 
bacterium Cutibacterium acnes (C. acnes), and host inflammatory responses. Increased sebum 
secretion from the pilosebaceous unit contributes to the pathogenesis of acne and likely triggers 
the inflammatory response that clinically present as comedones, papules, pustules, and nodules 
(Smith and Thiboutot 2008, Zouboulis, Jourdan et al. 2014, Lovaszi, Mattii et al. 2017). The 
main lipid components of sebum include squalene, triglycerides, free fatty acids, wax ester, 
cholesterol, and cholesteryl ester (Smith and Thiboutot 2008). These lipids can affect the growth 
of bacteria as well as host immune response. Lipids that accumulate in the follicular duct are 
oxidized by C. acnes lipase leading to bacterial proliferation and production of free fatty acids 
(Smith and Thiboutot 2008). Free fatty acids are a chemoattractant for macrophages and 
neutrophils resulting a cascade of immune cell recruitment and secretion of proinflammatory 
mediators. C. acnes, when supplied with a lipid substrate, can generate high levels of short 
chain fatty acids through anaerobic fermentation that modulate inflammatory gene expression 
from sebocytes, keratinocytes (KCs), and monocytes (Sanford, Zhang et al. 2016, Sanford, 
O'Neill et al. 2019). Squalene, a unique epidermal lipid in human sebum (Smith and Thiboutot 
2008), also has multiple effects on the immune response (De Jong, Cheng et al. 2014, Lovaszi, 
Mattii et al. 2017) such that it is currently being used as an adjuvant, MF59, in FLUAD flu 
vaccine (O’Hagan, Ott et al. 2013). As a result, it has been suggested that lipids such as fatty 
acids and squalene may play a role in inducing the inflammatory process in acne.  
Inflammation localized to the pilosebaceous unit is often the defining feature of acne. 
Patients are often concerned about the redness, pain, post-inflammatory hyperpigmentation, 
and scars that are associated with inflammation-induced damage (Thiboutot, Dreno et al. 2018). 
IL-1α/β are both expressed in early inflamed lesions and have been hypothesized to be the 
driver of the inflammatory cascade. The addition of IL-1α to KC culture was shown to activate 
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the hyperkeratinization process observed in comedones (Guy, Green et al. 1996). IL-1β can 
activate endothelial cells and signals for the migration of fibroblasts (Latkowski, Freedberg et al. 
1995, Freedberg, Tomic-Canic et al. 2001, Kistowska, Gehrke et al. 2014). Elevated levels of 
CD4+ T cells, CD68+ macrophages, CD83+ dendritic cells (DCs), and foamy macrophages have 
all been identified in acne lesions (Jerne 1984, Jeremy, Holland et al. 2003, Kelhala, Palatsi et 
al. 2014, Lovaszi, Mattii et al. 2017). However, the cellular components and mechanisms that 
initiate and perpetuate inflammation in acne are still unclear.  
Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful tool to deconstruct 
genetic and molecular profiles of individual cells, requiring few cells for analysis, such that it is 
readily possible to study immune cells from disease lesions (Papalexi and Satija 2018). In 
recent years, scRNA-seq methods are quickly becoming the technique of choice to study 
heterogeneous populations in complex tissues. The transcriptional signatures identified in these 
studies have enabled the identification of novel pathogenic biomarkers as well as reconstruct 
developmental trajectories to reveal cell fate decisions (Trapnell, Cacchiarelli et al. 2014). While 
RNA sequencing and microarrays have been performed on acne lesions, scRNA-seq studies 
provide more detailed transcriptional analysis of individual cells allowing for analysis of changes 
within the same cell types (Trivedi, Gilliland et al. 2006, Kelhala, Palatsi et al. 2014). As a result, 
we sought out to investigate these differences in acne that may have important implications for 
the understanding of the disease. 
 
Results 
Cell Types Recovered in Lesional and Non-lesional Acne 
 To elucidate cell heterogeneity and dynamic cellular changes in acne, we performed 
scRNA-seq on lesional (papules) and non-lesional skin from six individuals with active acne 
vulgaris (Supplementary Table 1.1). After application of quality control filters using Seurat 
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(Butler, Hoffman et al. 2018, Stuart, Butler et al. 2019), we subsequently included a total of 
32,966 cells from lesional skin and 29,202 cells from non-lesional skin for the scRNA-seq 
analysis. Gene expression data obtained from cells from both lesional and non-lesional skin 
were aligned and projected onto a two-dimensional space UMAP (Uniform Manifold 
Approximation and Projection). Unsupervised clustering revealed eight major clusters 
corresponding to seven different cell types each cluster with a mixture of lesional and non-
lesional cells (Fig. 1.1a-c). Within the myeloid, KCs, fibroblast, and endothelial cell clusters, the 
cells from lesional versus non-lesional samples were localized to distinct regions (Fig. 1.1b). 
Using differentially expressed genes and established canonical markers, we manually assigned 
cell type identities to endothelial cells (SELE, PECAM, VWF), fibroblasts (COL1A1, COL3A1, 
COL6A2), lymphoid cells (TRBC2, CD3D, TRAC), KC 1 (KRT1, KRT10, smooth muscle 
(TAGLN, ACTA2), myeloid cells (LYZ, HLA-DRA, CD83), KC 2 (MUCL1, KRT7, KRT18), and 
melanocytes (MLANA, DCT, PMEL) (Fig. 1.1d).  
 
Unique Myeloid Cell Types Associated with Acne Lesions  
To determine the range of biological diversity between lesional and non-lesional skin 
myeloid cells, we sub-clustered 2,638 myeloid cells and found six populations: three DC sub-
clusters and three macrophage sub-clusters (Fig. 1.2a-d). The three DC sub-clusters were 
defined as CD1C+ DC, Langerhans cells (LC), and LAMP3+ DC (Fig. 1.2b). CD1C+ DC 
expressed the cluster defining genes CD1C and CLEC10A (Fig. 1.2c, 2e). LC are antigen-
presenting cells that reside in the epidermis tasked with maintaining tissue homeostasis. Here, 
LC expressed the classic markers CD207 and CD1A (Fig. 1.2d, 2e), sharing a similar gene 
expression profile with migrating LCs including cytoskeleton remodeling (ACTB, DSP, PFN1 
and PLEK2) (Polak, Thirdborough et al. 2014, Artyomov, Munk et al. 2015). Cells in the LAMP3+ 
DC sub-cluster are predominantly derived from lesional skin (Fig. 1.2c-d), and were 
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characterized by expression of LAMP3, as well as the DC maturation markers CD80 and CD83 
(Fig. 1.2e), migration marker CCR7, and chemokines CCL17 and CCL19 consistent with similar 
cells identified in hepatocellular carcinoma (Polak, Thirdborough et al. 2014). The LAMP3+ DC 
from acne lesions also expressed CD274 (PD-L1) and PDCD1LG2 (PD-L2) suggesting LAMP3+ 
DC may employ the PD-1/PDL-1/PDL-2 axis to regulate peripheral tolerance (Weber, Meiler et 
al. 2011, Zhang, He et al. 2019).  
We annotated two macrophage sub-clusters as M1-like macrophages and M2-like 
macrophages, distinguished based upon the expression of characteristic genes (M1-like: IL1A, 
IL1B, TNF, IL6, IL12B, and M2-like: CD163, MRC1 (CD206), TGFB1, IL10 (Fig. 1.2d, 2f). 
Analysis of the third and largest macrophage sub-cluster, which is over 95% associated with 
lesional skin, expressed triggering receptor expressed on myeloid cells 2 (TREM2) and APOE 
(Fig. 1.2f), along with a set of genes involved in lipid transport consistent with a defined 
population known as “TREM2 macrophages” (Keren-Shaul, Spinrad et al. 2017, Lavin, 
Kobayashi et al. 2017, Cochain, Vafadarnejad et al. 2018, Jaitin, Adlung et al. 2019, Wang, Dai 
et al. 2019, Xiong, Kuang et al. 2019, Xue, Tabib et al. 2020). 
 
KCs in the Hair Follicles Present in Acne Lesions are Capable of Squalene Synthesis  
 Given that KCs constitute approximately 90% of cells in the epidermis, we wanted to 
profile how KCs differ between lesional and non-lesional acne specimens. We subclustered 
8,271 KCs into five populations including spinous, basal, granular, eccrine gland, and hair 
follicle (Fig. 1.3a-d). Using known keratin-specific markers, we categorized KCs as spinous KC 
via KRT1 and KRT10 expression, KRT5 and KRT14 as basal KC, and FLG and KRT2 as 
granular KC (Fig. 1.3d) (Fuchs and Raghavan 2002, Zhang, Yin et al. 2019). Cells localized to 
the eccrine gland were identified by MUCL1 and DCD (Gerber, Hevezi et al. 2013) were only 
found in non-lesional skin (Fig. 1.3d). We were interested in the lesional-enriched sub-cluster of 
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KCs, which we designated as “hair follicle KC” based on its expression of KRT6B and KRT6C 
(Supplementary Fig. 1.1a) (Fuchs and Raghavan 2002). This sub-cluster highly expressed 
genes of the squalene and squalene epoxides synthesis pathway starting from FDFT1 
(squalene synthase) and SQLE (squalene epoxidase) whereas expression of LSS (lanosterol 
synthase), the enzyme required for the subsequent step in the cholesterol synthesis pathway, is 
reduced (Fig. 1.3e) (Singh, Gohil et al. 2019). The hair follicle sub-cluster also highly expressed 
HIF1A, a low oxygen-stress induced gene, hypothesized to contribute to the accumulation of 
squalene in sebocytes (Fig. 1.3e) (Smith and Thiboutot 2008). We did not observe any 
upregulation of genes for fatty acid synthesis (SCD) (Peck and Schulze 2016), wax ester 
synthesis (AWAT1, AWAT2) (Turkish, Henneberry et al. 2005), nor triglyceride synthesis 
(DGAT1, DGAT2) (Chitraju, Walther et al. 2019) (Fig. 1.3e). One of the terminal genes in 
cholesterol synthesis pathway, DHCR24, was upregulated in the keratinocytes, while DHCR7 
was not (Fig. 1.3e). Cholesterol synthesis requires both enzymes DHCR24 and DHCR7 to 
interact physically and functionally (Luu, Hart-Smith et al. 2015). Consistent with scRNA-seq 
data, FDFT1 and SQLE encoded protein expressions observed by immunohistochemical 
staining were greater in the pilosebaceous unit in acne lesions compared to healthy controls 
(Fig. 1.3f). We were not able to locate sebocytes using canonical markers such as epithelial 
membrane antigen (EMA) (also known as mucin 1, MUC1) or androgen receptor (AR) 
(Supplementary Fig. 1.1b). 
 
Diversity of Fibroblast and Endothelial Cells in Acne lesions 
We found five sub-clusters of fibroblasts with two sub-clusters that are lesional-specific 
(Supplementary Fig. 1.2a-d). Fibroblast sub-cluster 1, composed predominantly of cells derived 
from acne lesions, was characterized by expression of genes encoding metalloproteinase 
proteins such as MMP1, MMP3, and MMP9, consistent with previous microarray studies 
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(Supplementary Fig. 1.2e) (Kang, Cho et al. 2005, Trivedi, Gilliland et al. 2006). There are also 
many lipid-related genes in fibroblast sub-cluster 3, a lesional-enriched sub-cluster, such as 
APOE, ABCA1, ABCA8, APOL1, APOL2, APOL3, and PLIN2 (Supplementary Fig. 1.2e).  
We found ten sub-clusters of endothelial cells based on their expression of PECAM1 
and CDH5 (Supplementary Fig. 1.2f-j). To localize each sub-clusters, we used expression levels 
of LYVE1 (lymphatic endothelial marker), GJA4 and GJA5 (venule endothelial markers), and 
NR2F2 (arterial marker) (Supplementary Fig. 1.2j) (Sissaoui, Yu et al. 2020). Lesional enriched 
endothelial cell sub-clusters were sub-cluster 1 and sub-cluster 5, both of which are localized to 
the arterial region (Supplementary Fig. 1.2j).  
 
Diversity of Lymphocytes in Acne Biopsy Specimens 
 We detected five populations of lymphocytes including naïve CD4+ T cells (CD40LG and 
CCR7) (Lesley, Kelly et al. 2006), cytolytic T lymphocytes (CTL), regulatory T cells (Treg) 
(FOXP3 and CTLA4), NK cells, and B cells (JCHAIN, CD79A) in both lesional and non-lesional 
skin (Supplementary Fig. 1.3a-d). The CTL and NK sub-clusters variably expressed the mature 
CTL markers GZMB, PRF1 and GNLY, with the majority of the CTL expressing the immature 
marker GZMK (Supplementary Fig. 1.3e). Whereas NK cells and some CTL expressed NKG7, 
the CTL all expressed CD3D. We found a lymphoid sub-cluster designated as “naïve T cells” 
that expressed Th17 cell related cytokine genes including CCL20, CSF2, IL17A, IL17F, IL21, 
IL22, IL23, and IL26 as well as Th17 cell surface receptor genes such as IL23R and CCR6 
(Supplementary Fig. 1.3f). We detected similar levels of these Th17-associated gene 
expression in lesional and non-lesional skin.  
 
Characterization of TREM2 macrophages 
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We further investigated the nature of the TREM2 macrophages in acne lesions by 
comparing the sub-cluster signature to a curated set of 100 defined macrophage signatures 
including the SAVANT database, bulk RNA-seq analysis of M1 and M2 macrophages as well as 
seven scRNA-seq studies of TREM2 macrophages (Xue, Schmidt et al. 2014, Keren-Shaul, 
Spinrad et al. 2017, Lavin, Kobayashi et al. 2017, Lopez, Montoya et al. 2017, Cochain, 
Vafadarnejad et al. 2018, Gerrick, Gerrick et al. 2018, Jaitin, Adlung et al. 2019, Wang, Dai et 
al. 2019, Xiong, Kuang et al. 2019, Xue, Tabib et al. 2020). The top 100 gene signature for the 
TREM2 macrophage sub-cluster was most similar to TREM2 macrophages identified by scRNA-
seq in seven studies of diseases characterized by alterations in lipid metabolism, in particular 
the studies of lipid laden macrophages in obesity and foam cells in atherosclerosis (Fig. 1.4a) 
(Keren-Shaul, Spinrad et al. 2017, Lavin, Kobayashi et al. 2017, Cochain, Vafadarnejad et al. 
2018, Jaitin, Adlung et al. 2019, Wang, Dai et al. 2019, Xiong, Kuang et al. 2019, Xue, Tabib et 
al. 2020). The TREM2 macrophages in acne lesions were similar to TREM2 macrophages in 
lung cancer, Alzheimer’s disease and nonalcoholic fatty liver disease. We derived a list of 26 
conserved genes that were present in at least four of the seven scRNA-seq studies of TREM2 
macrophages (Supplementary Table 1.2), finding that 19 genes were present in the acne lesion 
TREM2 macrophage sub-cluster. Of the six conserved genes that were not acne signature 
genes, LGALS3, TYROBP, AIF1, C1QC, CTSA, and SAT1 were expressed by >50% of cells in 
the acne TREM2 macrophage sub-cluster (Supplementary Fig. 1.4), but were also detected in 
the other myeloid sub-clusters. 
We performed KEGG pathway analysis of the top 100 signature genes in the acne lesion 
TREM2 macrophage sub-cluster, revealing enrichment for pathways described as lysosomes, 
cholesterol metabolism, mineral absorption, phagosome, and PPAR signaling pathway (Fig. 
1.4b). Focusing on cholesterol/lipid metabolism, we identified by gene ontology analysis that 
TREM2 macrophages express genes that are involved in lipid transport and binding (APOC1, 
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APOE, CD14, LRP1, TREM2), lipid intracellular transport (NPC1, NPC2), lipid signaling 
(NR1H3), lipid efflux (ABCA1, APOE), lipid storage (PLIN2), and lipid metabolism (Fig. 1.4c-d). 
We also found that TREM2 macrophages in acne lesions expressed key pro-inflammatory 
cytokine genes IL18 (Fig. 1.4e). 
To validate expression of TREM2 in acne lesions, we performed immunohistochemistry, 
finding that TREM2 expression was greater in lesional and non-lesional skin from the same 
donor (Fig. 1.4f, Supplementary Fig. 1.2). By immunofluorescence staining, TREM2 colocalized 
with the macrophage marker CD68 in lesional skin compared to non-lesional skin (Fig. 1.4g). 
These results suggest TREM2 macrophages characterized by a lipid metabolic program and 
pro-inflammatory gene expression accumulate in acne lesions.  
 
Squalene-induced TREM2 Expression in Macrophages 
 The presence of TREM2+ macrophages in acne lesions suggests a role in the 
pathogenesis of the disease. We used Ingenuity Pathway Analysis (IPA) to analyze the top 100 
genes from TREM2 macrophage cluster marker to identify cytokines that could drive the 
development of TREM2 macrophages. IFNG, IL13, TNF, IL1B, and IL4 were the top 5 upstream 
regulators. Consistent with the detection of IL-4 as an upstream regulator, it has been reported 
that IL-4, in combination with macrophage colony-stimulating factor (M-CSF), induces TREM2 
expression on macrophages in vitro (Turnbull, Gilfillan et al. 2006, Trapnell, Cacchiarelli et al. 
2014). We tested the upstream regulators in culture, with and without M-CSF, for their ability to 
induce TREM2 expression on adherent macrophages. Given that we determined that squalene 
synthesis is upregulated in hair follicle keratinocytes, we were interested in whether squalene 
can induce TREM2 expression. After five days of culture, the media was washed, and cells 
were incubated for two additional days with media control, a panel of cytokines, and squalene. 
Media control cells showed minimal upregulation of TREM2 expression (Fig. 1.5c). In contrast, 
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subsequent co-culture of five-day M-CSF derived macrophages with IL-4 or squalene in the 
presence of M-CSF markedly upregulated TREM2 expression as compared to M-CSF alone 
(Fig. 1.5c). Squalene induced TREM2 expression in macrophages in a dose-dependent manner 
(Supplementary Fig. 1.3). The gene expression profile measured by qPCR of squalene-treated 
macrophages is very similar to those of TREM2 macrophages in acne lesions (Fig. 1.5d). The 
lipid efflux transporter, ABCA1, and fatty acid metabolism enzyme, LPL, SPP1, and TREM2 are 
upregulated in squalene-treated macrophages (Fig. 1.5d).  
BODIPY staining revealed that the cytoplasm of squalene/M-CSF treated macrophages 
is full of lipids as compared to IFN-γ/LPS- and IL-4/M-CSF macrophages (Fig. 1.6a). We found 
squalene/M-CSF macrophages to have enhanced phagocytosis of latex beads and C. acnes 
when compared to IFN-γ/LPS and M-CSF macrophages (Fig. 1.6b-c). Squalene/M-CSF 
macrophages did not have measurable antimicrobial activity against C. acnes (Fig. 1.6d). We 
also observed squalene/M-CSF to secrete higher IL-1β and IL-18 when stimulated with live C. 
acnes as compared to IFN-γ/LPS and IL-4/M-CSF macrophages (Fig. 1.6d) consistent with the 
expression of these genes in TREM2 macrophages in acne lesions (Fig. 1.6e).  
 
Discussion 
Acne is a multifactorial disease involving excess lipid production from the sebaceous 
hair follicle and increased colonization by the commensal C. acnes, resulting in a host 
inflammatory response that underlies the clinical appearance of erythematous papules. We 
investigated the cellular response at the site of disease in acne by performing scRNA-seq on 
skin biopsy specimens from patients. We identified a subset of TREM2+ macrophages in acne 
lesions, characterized by a gene program the encodes lipid uptake, metabolisms, storage, and 
efflux, as well as expression of proinflammatory cytokines. A key component of human sebum, 
squalene, induced the TREM2+ macrophage program in vitro resulting in the enhanced 
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phagocytosis of C. acnes with the production of IL-18 (Fig. 1.6c), without a concomitant 
antimicrobial response (Fig. 1.6d). These data indicate that the excess lipid production triggers 
the induction and activation of TREM2+ macrophages resulting in inflammation that 
characterizes the clinical presentation of acne vulgaris.  
TREM2 is a transmembrane glycoprotein that can interact with lipoproteins, 
phospholipids, and anionic ligands (Daws, Sullam et al. 2003, Cannon, O’Driscoll et al. 2012, 
Wang, Cella et al. 2015), facilitated by the lipid transporter APOE. The TREM2+ macrophages in 
acne lesions were characterized by the upregulation of 24 genes involved in lipid transport and 
metabolism including APOE. Other genes in the TREM2+ macrophage lipid metabolism include 
ABCA1, the key efflux transporter of lipids, which is upregulated in the activation of liver X 
receptor (LXR) (Costet, Luo et al. 2000). We also see evidence of lipid processing in TREM2 
macrophages with the increase expression of cathepsins (CTSB, CTSD), lysosomal acid lipase 
A (LIPA), acetyl-coA acetyltransferase 1 (ACAT1, gene SOAT1), intracellular lipid transporters 
such as Niemann-Pick disease (NPC1, NPC2) as well as a marker for intracellular storage of 
lipid droplets perilipin 2 (PLIN2) (Fig. 1.4d). Excess lipids activate LXRs (gene NR1H3) to 
upregulate ABCA1 as well as lipid carrier APOE to facilitate efflux (Fig. 1.4d). The uptake of 
lipids by macrophages is mediated by micropinocytosis and various cell surface receptors. 
Instead of limiting lipid uptake of lipids, they largely depend on cholesterol efflux pathways to 
maintain cellular lipid homeostasis (Lovaszi, Mattii et al. 2017, Batista-Gonzalez, Vidal et al. 
2019). The gene expression suggests there is an active effort by these macrophages to 
upregulate metabolism, storage, and the efflux response to deal with the lipid accumulation. The 
presence of TREM2+ macrophages in acne lesions along with the finding that squalene, a lipid 
that is abundant in acne, induces and activates TREM2+ macrophages, indicating that TREM2+ 
macrophages are part of the host response to extracellular lipids.   
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TREM2+ macrophages have recently been a major focus in Alzheimer’s disease as 
studies revealed that variants of TREM2 increase the risk of early-onset disease and its 
increased lipids (such as Aβ deposits) phagocytosis may contribute to Aβ aggregates and tau 
pathology (Ruiz, Dols-Icardo et al. 2014, Slattery, Beck et al. 2014, Yao, Coppola et al. 2019). 
TREM2+ macrophages have also been detected in a wide range of inflammatory diseases 
characterized by alternations in lipid metabolism including obesity, atherosclerosis, lung cancer, 
and nonalcoholic fatty liver disease (Keren-Shaul, Spinrad et al. 2017, Lavin, Kobayashi et al. 
2017, Cochain, Vafadarnejad et al. 2018, Jaitin, Adlung et al. 2019, Wang, Dai et al. 2019, 
Xiong, Kuang et al. 2019, Xue, Tabib et al. 2020), thus representing a conserved and general 
macrophage response to excess extracellular lipids. Using the patterns of upregulated cluster 
specific marker genes of the seven scRNA-seq studies of these TREM2-associated diseases, 
we derived a list of 26 conserved genes that were present in at least four of the seven TREM2 
macrophage cluster markers (Supplementary Table 1.2). This included 19 genes that were 
present in the acne TREM2 macrophage gene signature. While six of the 26 common genes 
were not part of the acne TREM2 macrophage signature but were strongly expressed by these 
and other macrophage sub-clusters in acne. Only SYNGR1 (synaptogyrin 1) was absent in acne 
TREM2 macrophages, yet this gene encodes a membrane protein associated with presynaptic 
vesicles in neuronal cells (Verma, Kubendran et al. 2005). The 15 core signature genes encode 
for a lipid metabolism program that involves ACAA2, CEBPA, GALC, GBA, GLB1, HSD3B7, 
LEPROT, LIPA, LPL, LRP1, NCEH1, SCD, SOAT1, SPHK1. The 70 genes defined as lipid 
metabolism genes in the acne TREM2+ macrophage cluster that were not part of the TREM2 
macrophage seven studies consensus included genes that encode proteins involved in lipid 
transport (APOC1, CD14), metabolism (GLUL, NCEH1), storage (PLIN2), and signaling 
(NR1H3). All 70 genes, except for PRXL2B (encodes prostamide/prostaglandin F Synthase), 
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are present in at least two of the consensus studies. This indicates TREM2+ lipid-associated 
signature is conserved throughout various inflammatory and metabolic diseases.  
TREM2 expression in vitro is induced by M-CSF and IL-4, factors often used to 
differentiate monocytes to M2 macrophages (Turnbull, Gilfillan et al. 2006). This is evident in our 
macrophage sub-cluster as TREM2+ macrophages express similar levels of CD163, MRC1, 
TGFB1, and IL10 as M2-like macrophages (Fig. 1.2f). Using pseudotime analysis in 
combination with IPA, we identified TNF, IFNG, IL4, and IL1B (Fig. 1.5a) as potential regulators 
that have been observed experimentally to upregulate genes in TREM2+ macrophages. We 
found IL-4, consistent with previous studies (Turnbull, Gilfillan et al. 2006) and squalene induced 
TREM2 expression in vitro in presence of M-CSF (Fig. 1.5c). We noted that TREM2 is 
downregulated in response to IFN-γ consistent with a previous study (Turnbull, Gilfillan et al. 
2006), while M-CSF, TNF-α, and IL-1β has a minimal effect on TREM2 expression (Fig. 1.5c). 
We also observed squalene/M-CSF-treated macrophage expressed similar pattern of lipid-
related genes and secrete IL-1β and IL-18 similar to TREM2 macrophages in acne lesion (Fig. 
1.4e). IL-1β is known to drive the host inflammatory responses in C. acnes infected monocytes 
and mouse model (Kistowska, Gehrke et al. 2014). Free fatty acids and triglycerides can 
activate macrophages to synthesize IL-18 (Murphy, Kraakman et al. 2016). Serum IL-18 levels 
in obese individuals was found to correlate strongly with metabolic syndrome and insulin 
resistance (Esposito, Pontillo et al. 2002, Hung, McQuillan et al. 2005).The cytoplasm of these 
macrophages is filled with lipids, as seen with BODIPY stain (Fig. 1.5a), which are 
characteristics of foam cells found in acne lesions (Lovaszi, Mattii et al. 2017). These squalene-
treated macrophages exhibited enhanced phagocytosis, yet no antimicrobial activity against C. 
acnes compared to IFN-γ/LPS and IL-4/M-CSF-treated macrophages. Squalene had been 
shown to be an autoantigen in the activation of T cells as well as promote the differentiation of 
macrophages in the absence of C. acnes (De Jong, Cheng et al. 2014, Lovaszi, Mattii et al. 
27 
 
2017). These results suggest that the presence of excess squalene may enhance the 
macrophage’s ability to phagocytose but compromise its ability to kill bacteria. Without its 
antimicrobial activity, C. acnes growth will remain unchecked in the hair follicle and possibly in 
phagolysosomes, contributing to inflammation.  
We found evidences of squalene production and lipid metabolisms in other cells in acne 
lesions. A sub-cluster of hair follicle KC expressed high levels of FDFT1 and SQLE. FDFT1 
catalyzes the conversion of two molecules of farnesyl pyrophosphate (FPP) to squalene while 
SQLE is the first oxygenation step in cholesterol biosynthesis. SQLE is thought to be one of the 
rate-limiting enzymes in this pathway converting squalene to squalene epoxide in order to 
continue the biosynthesis pathway of lanosterol and eventually cholesterol (Singh, Gohil et al. 
2019). The buildup of squalene in sebaceous gland with little conversion to lanosterol have 
been attributed to the anaerobic environment of the pilosebaceous unit during comedone 
formation (Smith and Thiboutot 2008). Evidently, we found high expression of HIF1A in the hair 
follicle KC sub-cluster. As KCs in the hair follicle experience hypoxia, they try to increase 
expression of SQLE to continue the cholesterol synthesis pathway but instead create a 
bottleneck halting the lanosterol synthesis, which we observed as a low expression of LSS (Fig. 
1.3e). Other enzymes involved in fatty acid synthesis (SCD), wax ester synthesis (AWAT1, 
AWAT2), triglyceride synthesis (DGAT1, DGAT2), and cholesterol synthesis (DHCR7) were not 
upregulated in the hair-follicle keratinocytes (Fig. 1.3e) suggesting higher amounts of squalene 
products are made in the acne-associated hair-follicle compared to the other sebum-associated 
products. Although DHCR24 is upregulated, the terminal step of cholesterol synthesis requires 
both DHCR7 and DHCR24 to physically and functionally bind (Luu, Hart-Smith et al. 2015). We 
also detected a lesional-enriched sub-cluster of fibroblasts that also upregulated genes related 
to lipid transport and storage. This finding suggests that other cells in acne lesions are also 
finding ways to deal with the excess lipids. 
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Thus, we proposed that acne vulgaris initiates inflammation with the production squalene 
and squalene epoxides in the hair follicles. The accumulation of squalene and its derivatives 
upregulate the expression of TREM2 on macrophages. TREM2 expression enhances the 
phagocytosis ability of the macrophages to uptake lipids and bacteria. However, the surplus of 
lipids overwhelmed and immobilized the macrophages making them unable to kill the 
intracellular bacteria. TREM2+ macrophages upregulate expression and processing of IL-18 to 
activate the immune response. At the same time, some TREM2+ macrophages may undergo 
apoptosis releasing excess bacteria and lipids which further activate the immune response 
leading to inflammation (Fig. 2.2). 
One limitation of our scRNA-seq data is the failure to detect sebocytes. Given the lack of 
scRNA-seq signature for sebocytes and possible lysis of sebocytes during tissue processing, 
we were unable to locate a sebocyte population, even when we used MUC1 and AR 
(Supplementary Fig. 1.1). This could also be a limitation of scRNA-seq data where some 
transcripts are not detected in all cells, resulting in dropouts or a false-negative read count (20). 
Given the limitation of our data, the hair follicle KC sub-cluster we attributed the high expression 
of FDFT1 and SQLE to these cells, which could be sebocytes. Our analysis did not detect 
differences in the T cell compartment between skin biopsy specimens from acne lesions as 
compared to non lesional skin, differing from one of two cohorts in a microarray study (Kelhala, 
Palatsi et al. 2014). Some of the Th17 cytokines such as IL17A, IL17F, IL21, IL22, present in 
acne lesions, are not readily detected by the single cell platform, 10X Genomics.  Also, the 
failure to detect gene changes in acne lesions compared to non-lesional skin may be due to the 
acne severity in our subjects. Of the six acne subjects, three had mild and three had moderate 
acne. This was possibly due to our strict exclusion criteria of no acne medication or hormonal 
regulation medication or implants in the past three months. As a result, the acne biopsies may 
not have been in a chronic inflammation stage and, possibly, were still in the early inflammatory 
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stage. It would be relevant to determine how immune cells in acne lesions vary with increased 
severity of acne. 
Our results underline the importance of squalene in the initiation of inflammation in acne, 
it would be interesting to see whether squalene could be a potential target for acne therapy. 
Squalene is a unique lipid component of human sebum (Lovaszi, Mattii et al. 2017) and also 
found in greater proportions on acne patients compared to no acne controls (Pappas, Johnsen 
et al. 2009). Current animal models of acne do not fully mimic the diseased features in humans. 
Some studies have used topical application of human sebum, to promote the survival of bacteria 
after intradermal injection in mice (Kolar, Tsai et al. 2019).  A recent phase-three trial using 
small molecule inhibitor of acetyl coenzyme A (CoA) carboxylase (ACC) to affect fatty acids 
biosynthesis failed to see a reduction in the number of inflammatory lesions (Bissonnette, Poulin 
et al. 2017). Interestingly, the small molecular inhibitor blocks the synthesis free fatty acids, wax 
esters, and triglycerides in the sebum but has no effects on squalene or cholesterol synthesis 
(Bissonnette, Poulin et al. 2017). Thus, squalene represents an attractive therapeutic target 
given its central role in the formation of sebum, a key factor involved in acne development.   
 
Materials and Methods 
Healthy Blood donors, skin samples, and single cell library preparation 
The study was performed in accordance with protocols approved by the institutional review 
board at University of California, Los Angeles. All patients provided written informed consent. 
Healthy blood and acne donors were recruited from the University of California, Los Angeles. 
Patients were excluded from the study if they had been using acne medication, hormonal 
regulation medication, or hormonal-related implants in the past three months. Skin samples 
were obtained from 3mm punch biopsies in the back. Briefly, skin was digested enzymatically at 
2 hours with 0.4% Dispase II at 37°C with agitation. The epidermis was separated from the 
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dermis. Epidermis was then treated with 0.25% Trypsin and 10U/mL of DNAse I for 30 minutes. 
Dermis was homogenized and treated with 0.4% Collagenase II and 10U/mL DNase I for 2 
hours. Isolated cells were loaded into the Chromium instrument (10X Genomics) according to 
manufacturer’s protocol and analyzed using Seurat (19, 20). Pseudo-time trajectories for 
macrophage cluster were constructed using Monocle 2, an R package (45).  
 
Immunohistochemical and Immunofluorescence staining 
Frozen tissue sections were blocked with normal horse serum before incubation 2 hours 
with mAbs against FDFT1, SQLE, and TREM2 (Invitrogen) followed by incubation with 
biotinylated horse anti–mouse IgG for 90 minutes. Slides were counterstained with hematoxylin 
and mounted in crystal mounting medium (Biomeda) and were visualized using the ABC Elite 
system (Vector Laboratories). Skin sections were examined with a Leica microscope. 
Cryosections (4mm) from acne patients was incubated with antibodies against and 
CD68 (BD) followed by Alexa Fluor 594 isotype specific secondary (Invitrogen). Sections were 
washed, incubated with monoclonal antibodies for TREM2 (Thermo Scientific) followed by and 
Alexa Fluor 647 isotype-specific secondary (Invitrogen). Slides were mounted in crystal 
mounting medium (Biomedia) then preserved with Prolong Gold with DAPI (Invitrogen). 
Colocalization analysis was performed with Leica Application Suite X (LAS X).  
Differentiated macrophages were fixed with 4% paraformaldehyde onto a poly-L-lysine 
coated microscope slide. Sections were washed and incubated with BOPIDY at for 1 hour at 
room temperature. Slides were then preserved with Prolong Gold with DAPI (Invitrogen). 
Colocalization analysis was performed with Leica Application Suite X (LAS X).  
 
Gene overlap, functional, and upstream regulator analyses 
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Gene overlap used the top 100 genes of TREM2 macrophage sub-cluster and various 
macrophage signatures. Significance (-log(p-value)) of the overlap was calculated using 
hypergeometric test assuming 22,792 unique human genes. KEGG pathway analysis was 
performed using top 100 genes of the TREM2 macrophage sub-cluster via Enrichr (60, 61). 
Lipid specific Gene Ontology terms was performed using the ClueGO plugin (Cytoscape) (62). 
Upstream Regulator Analysis in Ingenuity Pathways Analysis (Qiagen) with the genes obtained 
from pseudo-time analysis.  
 
Macrophage Characterization 
Monocytes were isolated from healthy donor blood using a Ficoll (GE Healthcare) 
density gradient and adhered for 2 hours with RPMI supplemented with 1% fetal calf serum 
(FCS). Monocytes were seeded at 500,000 cells/well in 24-well plate and differentiated in M-
CSF (50 ng/ml) (R&D System) for 5 day in RPMI with 10% FCS at 37°C. Macrophages were 
then stimulated with LPS (100ng/mL) + IFN-γ (20ng/mL) for 1 day, M-CSF (50 ng/ml), IL-4 
(20ng/mL), squalene (5 μM), TNF-a (1μg/ml) (Thermo Scientific), IL-1β (0.1 μg/mL) (Thermo 
Scientific), IFN-γ (1 μg/mL) (Thermo Scientific). Squalene was sonicated for 30 minutes in RPMI 
prior to adding to macrophage culture. Adherent cells were detached with 1mM EDTA in PBS. 
Cells were stained with APC-conjugated mAbs against TREM2 (R&D System). Isotype controls 
were performed in parallel. Cells were acquired with LSR II flow cytometer (BD) and analyzed 
with FlowJo (BD). 
 
RNA isolation and reverse transcription-real time quantitative PCR analysis 
Total RNA was isolated at 12 hours and 24 hours using TRIzol (Invitrogen) according to 
manufacturer’s protocol. First strand cDNA synthesis was performed with iScript cDNA 
synthesis kit (BioRad). Total RNA was subjected to reverse transcription-quantitative 
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polymerase chain reaction (RT-qPCR) via Bio-Rad IQ5 system using iQ SYBR Green Supermix 
(BioRad). The relative quantities of gene tested per sample were calculated against GAPDH 
using ∆∆CT. Human specific probes were generated by RT-qPCR amplification using the 
following primer sets: ABCA1 for 5’-AACAGTTTGTGGCCCTTTTG-3’, ABCA1 rev 5’-
AGTTCCAGGCTGGGGTACTT-3’, ABCG1 for 5’- CCTTTCCTATTCGGTTCCTGA-3’, ABCG1 
rev 5’- TTCCTTTCAGGAGGGTCTTG-3’, APOE For 5’-CCAGCGGAGGTGAAGGAC-3’, APOE 
Rev 5’-CGCTTCTGCAGGTCATCG-3’, LPL For 5’-GAGATTTCTCTGTATGGCACC-3’, LPL rev 
5’-CTGCAAATGAGACACTTTCTC-3’, SCD1 For 5’-TGCCCACCTCTTCGGATATC-3’, SCD1 
Rev 5’-GATGTGCCAGCGGTACTCACT-3’, SPP1 For 5’-GCCGCTGTAACCTCTTCGG-3’, 
SPP1 Rev 5’-GTCTTCGGCCAATCTGGCTTT-3’, TREM2 For 5’-
GCCTGACATGCCTGATCCTC-3’, TREM2 Rev 5’-AGGACCTTCCTGAGGGTGTC-3’, GAPDH 
For 5’-GGATTTGGTCGTATTGGG-3’, GAPDH Rev 5’-GGAAGATGGTGATGGGATT-3’.  
 
Bacterial Culture 
Single colonies of C. acnes HL096PA1 were inoculated into 5 mL of Reinforced 
Clostridial Media (RCM) (Oxoid) and cultured at 37°C under anaerobic conditions until early 
logarithmic growth phase (OD600 = 0.1 – 0.3). Bacteria pellets were harvested by centrifugation 
at 5,000xg for 10 minutes and washed with PBS three times. C. acnes were labeled using 
PKH26 general cell membrane labeling kit (Millipore) according to manufacturer’s protocol.  
 
ELISA 
In vitro macrophages generated as described above with LPS (100ng/mL) + IFN-γ 
(20ng/mL) for 1 day, M-CSF (50 ng/ml), IL-4 (20ng/mL) and squalene (5 μM) for 2 days. 
Cytokine and squalene-treated macrophages were washed three times with PBS. C. acnes was 
added at MOI 10 to 500,000 macrophages per well in a 24-well plate. After 24 hours of 
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stimulation, IL-1β (R&D Systems) and IL-18 (R&D Systems) release was measured by ELISA 
according the manufacturer’s protocol. 
 
Phagocytosis Activity 
Macrophages were incubated with PKH26-labelled C. acnes or latex beads (Millipore 
Sigma) for 24 hours. Cells were prepared with cold PBS washing and extracellular bacteria 
were killed with 300 μg/mL gentamicin (Sigma Aldrich). Cells were then acquired with LSR II 
flow cytometer (BD) and analyzed with FlowJo (BD). 
 
Antimicrobial Assays 
Macrophages were incubated with bacteria at MOI 10 for 1 hour and 24 hours at 37°C. 
Cells were washed 3 times with cold PBS. Extracellular bacteria were killed with 300 μg/mL 
gentamicin (Sigma Aldrich). Cells were lysed with a 10 minutes treatment with 0.5% saponin. A 
dilution series was plated on Brucella agar with 5% Sheep Blood (Thermo Scientific) to 
determine viable intracellular bacteria by CFU (colony forming unit) counting after 5 days of 
incubation at 37°C using Anaeropack (Thermo Scientific). Antimicrobial activity was calculated 
by subtracting the 24-hour CFU count with the 1-hour CFU count and divided by the 1-hour CFU 
count to determine the percentage of killing. 
 
Statistical Analysis.   
Statistical analyses were calculated using GraphPad Prism version 8.0, and p values ≤ 
0.05 were assigned as significant. For comparisons involving two groups, a paired Student t test 
or one-way ANOVA with Sidak posttest was performed. For more than two comparison groups, 
a one-way ANOVA with Tukey posttest, a two-way ANOVA with Tukey posttest, or a Friedman 
test with Dunn posttest was performed. Data are represented in figures as mean ± SEM. 
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Fig. 1.1. Cell Types Recovered in Lesional and Non-lesional Acne 
a. UMAP plot for 62,168 cells from acne patients colored by cell type cluster.  
b. UMAP plot for 62,168 cells colored by lesional types with 32,966 cells from lesional skin and 
29,202 cells from non-lesional skin. Lesional cells are shown in red while non-lesional cells are 
shown in blue.  
c. Stacked bar-plot showing the donor and lesion type composition for each of the cell types. 
Lesional cells are shown in red while non-lesional cells are shown in blue.  
d. Heatmap showing normalized gene expression values for a curated list of cell type specific 
genes. High expression values are shown in yellow while low expression values are show in 
purple. 
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Fig. 1.2. Unique Myeloid Cell Type Associated with Acne Lesions  
a. UMAP plot for 4,370 myeloid cells from acne patients colored by  cell types.  
b. UMAP plot for 4,370 myeloid cells colored by lesional types with 3,152 myeloid cells from 
lesional skin and 1,218 myeloid cells from non-lesional skin. Lesional cells are shown in red 
while non-lesional cells are shown in blue. 
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c. Stacked bar-plot showing the donor and lesion type composition for each of the cell types. 
Lesional cells are shown in red while non-lesional cells are shown in blue.  
d. Heatmap showing normalized gene expression values for a curated list of cell type specific 
genes. High expression values are shown in yellow while low expression values are show in 
purple.  
e. Violin plots showing the normalized expression levels for genes in DC sub-clusters. 
f. Violin plots showing the normalized expression levels for genes in macrophage sub-clusters. 
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Fig. 1.3. KCs in the hair follicles present in acne lesions is capable of squalene synthesis  
a. UMAP plot for 8,271 KCs from acne patients colored by cell types. 
b. UMAP plot for 8,271 keratinocytes colored by lesional types with 4,473 keratinocytes from 
lesional skin and 3,798 keratinocytes from non-lesional skin. Lesional cells are shown in red 
while non-lesional cells are shown in blue. 
c. Stacked bar-plot showing the donor and lesion type composition for each of the cell types. 
Lesional cells are shown in red while non-lesional cells are shown in blue.  
40 
 
d. Heatmap showing normalized gene expression values for a curated list of cell type specific 
genes. High expression values are shown in yellow while low expression values are show in 
purple. 
e. Violin plots showing the normalized expression levels of curated list of lipid biosynthesis 
pathways for keratinocyte sub-clusters.  
f. Immunohistochemistry staining of FDFT1 and SQLE encoded protein. Scale bar = 100 micron 
 
  
41 
 
 
  
42 
 
Fig. 1.4. Characterization of TREM2+ Macrophages 
a. Bar plot comparing the top 100 marker genes of the acne TREM2 macrophage subcluster s 
with top 100 genes of a selected list of macrophage signatures. Significance (-log(p-value)) of 
the overlap was calculated using hypergeometric test assuming 22,792 unique human genes.  
b. KEGG pathway analysis using the top 100 marker genes of the TREM2 macrophage 
subcluster via Enrichr (49, 50). 
c. Diagram illustrating the categories of lipid processing pathways based on gene ontology 
analysis 
d. Violin plots showing normalized expression of categories of lipid processing genes based on 
gene ontology analysis. 
e. Violin plot of normalized expression for IL18 in the macrophage sub-clusters. 
f. Immunohistology staining of normal skin (control) and acne lesions for TREM2 expression.  
g. Immunofluorescence staining in lesional and non-lesional acne skin biopsy samples for 
TREM2 and CD68 expression. Scale bar = 20 micron.  
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Fig. 1.5. Squalene Induce TREM2 Macrophage Differentiation 
a. Top 10 upstream regulators identified by IPA for top 100 marker genes of TREM2 
macrophage subcluster.  
b. Histogram showing the expression of surface TREM2 expression with IL-4 (20ng/mL), 
squalene (5 mM), TNF-a (1mg/ml), IL-1b (0.1 mg/mL), IFN-g (1 mg/mL), with or without M-CSF 
for 48 hours.  
c. Mean fluorescence intensity (MFI) of TREM2 expression with the different stimuli (n=3) 
without M-CSF 
d. Mean mluorescence intensity (MFI) of TREM2 expression with the different stimuli (n=3) with 
M-CSF 
e. Comparing scRNA-seq average percent of cell expressing lipid genes for donor with more 
than 10 cells expressing the marker genes with real-time PCR of fold change of relative gene 
expression to GAPDH.  
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Fig. 1.6. Squalene/M-CSF Macrophage Have Increased Phagocytosis but No 
Antimicrobial Activity Against C. acnes 
a. Immunocytochemical staining of in vitro stimulated macrophages. DAPI is in blue and 
BODIPY is in green. Scale bar = 20 microns. 
b. In vitro macrophages uptake of PE-labeled latex beads at varying concentrations, as 
measured by flow cytometry using MFI 
c. In vitro macrophages uptake PKH-26-labeled C. acnes, as measured by flow cytometry using 
MFI. Results are shown as mean ± SEM (n=3). *p <0.05. **p <0.01. Significance was calculated 
using one-way ANOVA with Tukey posttest 
d. Cytokine and squalene-treated macrophages were stimulated with C. acnes for at 1 and 24 
hours. Antimicrobial activity was calculated by subtracting 24-hour CFU (colony counting unit) 
count with 1-hour CFU count to determine the percentage of killing. Results are shown as mean 
± SEM (n=3). *p <0.05. **p <0.01. Significance was calculated using one-way ANOVA with 
Tukey posttest. 
e. In vitro cytokine and squalene-treated macrophages were stimulated with media or C. acnes 
for 24 hours. IL-1β and IL-18 in culture supernatant were measured by ELISA.  
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Fig. 1.7. Model of Acne Inflammation with TREM2+ Macrophage 
Activation of hair-follicle KCs leads to production squalene and squalene epoxides. The build-up 
of squalene and its derivatives upregulate the expression of TREM2 on macrophages. TREM2 
expression enhances the phagocytic capacity of the macrophages to uptake lipids and bacteria. 
However, these macrophages becomes immobilized and unable to kill the intracellular bacteria. 
TREM2+ macrophages upregulate expression and processing of IL-1β and IL-18 to recruit other 
immune cells. At the same time, some TREM2+ macrophages may undergo apoptosis releasing 
excess bacteria and squalene further activate the immune response leading to inflammation 
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Supplemental Table 1.1. Clinical characteristics of acne subjects. 
A table of clinical characteristics of acne patients. Acne severity at the biopsy site (back) was 
assessed by Global Evaluation Acne scale by a UCLA dermatologist.  
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Supplemental Table 1.2. 26 consensus signature genes from seven TREM2 macrophage 
studies 
 A table of genes in at least four of the seven TREM2 macrophage scRNA-seq studies 
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Supplemental Fig. 1.1. Undetectable Expression of Canonical Sebocyte Markers 
a. UMAP plots showing normalized expression of curated set of genes to identify keratinocyte 
sub-clusters 
b. UMAP plots showing normalized expression of MUC1 encoding epithelial membrane antigen 
(EMA) and AR. Higher expressions are shown in red, according to the scale shown. 
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Supplementary Fig. 1.2. Diversity of Fibroblasts and Endothelial Cells in Acne lesions 
a. UMAP plot for 6,735 fibroblasts from acne patients colored by sub-clusters.  
b. UMAP plot for 6,735 fibroblasts colored by lesional types with 4,103 fibroblast from lesional 
skin and 2,632 fibroblast from non-lesional skin. Lesional cells are shown in red while non-
lesional cells are shown in blue.  
c. Stacked bar-plot showing the donor and lesion type composition for each of the cell types. 
Lesional cells are shown in red while non-lesional cells are shown in blue.  
d. Heatmap showing normalized gene expression values for a curated list of sub-cluster specific 
genes. High expression values are shown in yellow while low expression values are show in 
purple. 
e. Violin plot showing normalized expression of a curated list MMPs, and lipid-related genes in 
fibroblast sub-cluster 1 and 3 genes. 
f. UMAP plot for 10,827 endothelial cells from acne patients colored by cell type cluster.  
g. UMAP plot for 10,827 fibroblast colored by lesional types with 5,257 endothelial cells from 
lesional skin and 5,570 endothelial cells from non-lesional skin. Lesional cells are shown in red 
while non-lesional cells are shown in blue.  
h. Stacked bar-plot showing the donor and lesion type composition for each of the sub-clusters. 
Lesional cells are shown in red while non-lesional cells are shown in blue.  
i. Heatmap showing normalized gene expression values for a curated list of sub-cluster specific 
genes. High expression values are shown in yellow while low expression values are show in 
purple. 
j. UMAP plots showing normalized expression of a curated list endothelial markers. Higher 
expressions are shown in red, according to the scale shown. 
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Supplementary Fig. 1.3. Diversity of Lymphocytes in Acne Biopsies 
a. UMAP plot for 3,893 lymphocytes from acne patients colored by cell types.  
b. UMAP plot for 3,893 lymphocytes colored by lesional types with 2,751 lymphocytes from 
lesional skin and 1,142 lymphocytes from non-lesional skin. Lesional cells are shown in red 
while non-lesional cells are shown in blue.  
c. Stacked bar-plot showing the donor and lesion type composition for each of the cell types. 
Lesional cells are shown in red while non-lesional cells are shown in blue.  
d. Heatmap showing normalized gene expression values for a curated list of sub-cluster specific 
genes. High expression values are shown in yellow while low expression values are show in 
purple. 
e. UMAP plots showing normalized expression of lymphocyte and NK cell markers. Higher 
expressions are shown in red, according to the scale shown. 
f. Violin plot showing normalized expression of a curated list Th17-related genes.  
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Supplemental Fig. 1.4. TREM2 Signature Genes and Expression Levels 
a. UMAP plots showing normalized expression of six conserved genes that were not acne 
signature genes from seven TREM2 macrophage scRNA-seq studies (24-30). Higher 
expressions are shown in red, according to the scale shown. 
b. Immunofluorescence staining of isotype for TREM2 (IgG3) and CD68 (IgG1) 
c. Histogram showing the expression of surface TREM2 expression with increasing 
concentration of squalene.  
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CHAPTER 3 
 
C. acnes RNA Stimulate IFN-γ Release in a TLR-8/IL-12/IL-18 Dependent Pathway 
 
Abstract 
Acne is a chronic inflammatory skin disease thought to be driven in part by the activation 
of the immune response to Cutibacterium acnes (C. acnes), a ubiquitous skin commensal. It has 
been reported that the relative abundance of C. acnes is similar in the follicles of acne patients 
compared to healthy controls. This suggests the presence of the bacteria alone does not lead to 
inflammation. Metagenomic analyses of the skin microbiome revealed a diverse population of C. 
acnes strains that are distinct between acne and healthy individuals. These strains also differed 
in their potential to trigger inflammation with strains enriched on the skin of acne patients (CA) 
induces higher pro-inflammatory cytokine compared to strains associated with clear or healthy 
skin (CH). However, the virulence factor that accounts for the differences in immune response 
between CA and CH are still unknown. In this study, we showed that C. acnes activates the 
innate immune system through RNA species that are usually reserved for viral detection. 
Interestingly, RNA species from CA and CH had different bioanalyzer profiles and triggered 
distinct immune response as seen with live bacteria. We also showed that CA RNA stimulate the 
immune response through a TLR-8/IL-18/IL-12p40 pathway. Our in vitro data correlated well 
with our single cell RNA-seq data showing the abundance of IFN-γ and TLR-8 in acne lesions. 
Our study suggests that RNA from CA triggers inflammatory response that contribute to the 
pathogenesis and clinical presentation of acne.   
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Introduction 
Microbes play a large part in the pathogenesis of disease (Rosenthal, Goldberg et al. 
2011). On the skin surface, the interplay within the microbial community is essential for the 
maintenance of healthy skin. Cutibacterium acnes (C. acnes) (formerly known as 
Propionibacterium acnes) is a Gram-positive, microaerophilic bacillus that is considered to be 
one of the factors driving inflammation in acne (Bhate and Williams 2013). However, the direct 
cause-and-effect relationship between the bacteria and the disease has been difficult to 
establish given that C. acnes is a ubiquitous bacterium and that there was no quantitative 
difference in the number of bacteria between subjects with and without acne (Barnard, Shi et al. 
2016). C. acnes has been shown to coexist in the pilosebaceous unit with other Cutibacterium 
spp. included C. granulosum and C. humerusii (Grice and Segre 2011).  
Recent genomic and phenotypic analyses provide new insights into the cellular 
physiology underlying the heterogeneity of the bacteria. Certain C. acnes strains, designated 
type IA1 or IC, identified by multi-locus sequence typing (MLST), were present in significant 
quantities in approximately 30–40% of patients with acne (CA). Conversely, the phylotype II, RT 
6 subgroup was found to be 99% associated with healthy skin  (CH) (Fitz-Gibbon, Tomida et al. 
2013, Tomida, Nguyen et al. 2013). The two divergent phylotypes also exhibited differences in 
inflammatory potential with CA inducing higher pro-inflammatory cytokine secretion from human 
peripheral blood mononuclear cells (PBMCs), Th17 clones, and murine model (Yu, Champer et 
al. 2016, Agak, Kao et al. 2018, Kolar, Tsai et al. 2019). 
Acne is characterized by inflammation localized to the pilosebaceous follicle, which 
promotes redness, pain, post-inflammatory hyperpigmentation, and scars that are associated 
with inflammation-induced damage (Thiboutot, Dreno et al. 2018). Although acne is a disease of 
the skin, the effects of acne go beyond the skin manifestations as studies have found that the 
clinical presence of inflammatory skin lesions impose a significant psychologic burden on 
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adolescents and young adults associated with low self-esteem (Nguyen, Koo et al. 2016), 
anxiety, depression, and suicidal ideation (Purvis, Robinson et al. 2006, Vallerand, Lewinson et 
al. 2018).  
Given the increasing recognition that commensal and mutualistic microorganisms are 
necessary for the maintenance of a healthy human physiology, it is essential that we understand 
how the different phylotypes in C. acnes modulate the inflammatory microenvironment. Thus, if 
we were able to identify the bacterial component from CA that promote inflammation, it may be 
possible to prevent inflammatory sequelae and promote skin homeostasis.  
 
Results:  
CA infection induces IFN-γ secretion at an early time point 
We hypothesized that the pro-inflammatory potential of CA is associated with a strain-
specific virulence factor. To investigate this, we stimulated peripheral blood mononuclear cells 
(PBMCs) with three CA isolates: HL5PA1, HL43PA1, and HL96PA1 and three CH isolates: 
HL42PA3, HL110PA3, and HL110PA4. While we found CA-treated PBMCs secrete higher 
amounts of pro-inflammatory, IFN-γ, TNF-α, and IL-1β, we noted the largest difference, 
approximately three-fold, in IFN-γ secretion among the CA and CH strains compared to 1.5-fold 
difference for TNF-α and IL-1β (Fig. 2.1a-c). 
To determine whether IFN-γ plays a role in innate and adaptive immune response in C. 
acnes infection, we studied the time course of IFN-γ secretion. Within six hours to C. acnes, 
significant IFN-γ secretion could be detected in cell supernatant compared to tetanus toxoid, a 
known adaptive immune response activator, which was not detectable until 24 hours after 
induction (Fig. 2.1d). IFN-γ secretion continued to increase throughout the seven-day period 
(Fig. 2.1d).  
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NK Cells are the main producer of IFN-γ  
We next determined which cells in PBMCs are responsible for the early IFN-γ response 
in C. acnes infection. We depleted CD3+ T cells, CD56+ NK cells, and CD14+ monocytes in 
PBMC culture as well as isolated and enriched for CD3+, CD56+, and CD14+ cells in culture and 
stimulated them with C. acnes (Fig. 2.2a-b). NK (CD56+) depletion significant decreased IFN-γ 
secretion while isolated NK cells were able to induce IFN-γ response (Fig. 2.2b). Intra-cellular 
flow cytometry confirmed CD56+CD3- NK cells to be the major producer of IFN-γ (Fig. 2.2c-d).   
 
TLR-8, IL-18, and IL-12p40 are required for IFN-γ secretion 
Since IL-18 and IL-12/IL-23 are known to synergistically trigger secretion of IFN-γ (Ziblat, 
Nuñez et al. 2018), we investigated their kinetics in response to C. acnes infection. We detected 
a robust IL-18 and IL-12p40 response as early as 6 hours and the levels are steadily maintained 
up until 24 hours as IFN- γ exponentially increased (Fig. 2.3a). Using neutralizing antibodies to 
IL-18 and IL-12p40, determined that the inhibition of IL-18 and IL-12p40 also impeded IFN-γ 
secretion (Fig. 2.3b). TLR-8 activation in monocytes is known to secrete IL-18 and IL-12/IL-23 
(Gorski, Waller et al. 2006, Keegan, Krutzik et al. 2018, Ziblat, Nuñez et al. 2018), which 
activate NK cells to produce IFN-γ (Gorski, Waller et al. 2006). Using a TLR8- inhibitor and an 
antagonist, we found TLR8 inhibition significantly decreased IFN-γ secretion. TLR-2 and TLR-4 
have been shown to play a role in C. acnes infection (Liu, Krutzik et al. 2005). We tested 
whether TLR-2, TLR-4, or TLR-8 play a role in IFN-γ secretion. The activation of TLR-2 and 
TLR-4 did not induce IFN-γ as expected and thus, their inhibition had no effect on IFN-γ 
secretion (Fig. 2.3d-e) These results suggest IFN-γ secretion in a C. acnes infection is regulated 
by TLR8, IL-18, and IL-12p40. 
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CA RNA induces higher secretion of IFN-γ, IL12p40, and IL-18 compared to CH RNA similar to 
the live bacteria response 
To determine which bacterial components were able to induce an IFN-γ response, we 
added live, heat-killed, RNase-treated, and DNAse-treated bacteria to PBMC culture. HK 
bacteria and RNase-treated bacteria did not induce an IFN-γ response (Fig. 2.4a). We also 
isolated bacterial supernatant, RNA, and DNA as well as placed PBMCs in a transwell (Fig. 
2.4b). We observed that bacterial supernatant and transwell experiment did not induce an IFN-γ 
response. Interestingly, when we transfected bacterial RNA and DNA with DOTAP, a cationic 
surfactant reagent to facilitate uptake, into PBMCs, we observed the secretion of IFN-γ at a 
similar level as the live bacteria (Fig. 2.4b). Bacterial RNA transfection had a more robust 
response compared DNA transfection (Fig. 2.4b).  
To address whether CA and CH RNA induce different immune responses, we isolated 
RNA from CA and CH and transfected them with DOTAP into PBMCs or monocyte-derived 
macrophages (MDMs). CA RNA induced higher IFN-γ, IL-18, and IL-12p40 secretion in PBMCs 
as seen with live bacteria (Fig. 2.4c-e). Although we did not detect any IFN-γ secretion in MDMs, 
we observed similar increase in IL-18 and IL-12p40 secretion in CA-treated cells (Fig. 2.4f).  
 
CA and CH harbor different species of bacterial RNA 
To identify differences in RNA species between the bacterial strains, we measured their 
lengths using a bioanalyzer. The bioanalyzer traces showed CA RNA predominantly ranges from 
25-200 nucleotides (nt) while CH RNA has peaks at a range of 25-200 nt and 1000-4000 nt (Fig. 
2.5a-b). We also isolated RNA species from other commensal inhabitants of the pilosebaceous 
gland such as: C. humerusii, and C. granulosum and their RNAs were similar to CH (Fig. 2.5c). 
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In vivo scRNA-seq data from acne lesions confirms higher expression of TLR8, IL18, and IFNG 
Lastly, we looked at whether the IL-18 to IFN-γ pathway may play a role in acne lesions. 
From our single cell RNA-seq data of acne lesions, we found more lesional cells expressing 
IFN-γ compared to non-lesional cells (Fig. 2.6 a). Lymphocyte, specifically cytotoxic T 
lymphocyte (CTL) was found to be the major producer of IFNG (Fig. 2.6b-c). IL18 was found in 
to be highly expressed in lesional macrophages that express TREM2 (triggering receptor 
expressed on myeloid cells 2). We also investigated the expression of the different TLRs in 
lesional and non-lesional skin. TLR8 expression is differentially expressed in lesional vs. 
nonlesional skin of acne patients. TREM2 macrophages also highly expressed TLR8. Finally, 
we looked at the z-scores calculated based on the expression of each cell type normalized 
across all samples to confirm that there are differences in lesional and non-lesional expression 
of TLR8, IFNG, and IL18 as described above (Fig. 2.6h). Indeed, TREM2 lesional-specific 
macrophage express higher levels of TLR8, IFNG, and IL18 (Fig. 1.13h). Moreover, CTL, naïve 
T cells, and NK cells lesional cells all express higher levels of IFNG (Fig. 2.6h). These results in 
scRNA-seq are very similar to what we observed in vitro. This suggests there are evidence of 
IFN-γ, IL-18, and TLR-8 activation in acne lesions.  
 
Discussion 
The interaction between microbiota and the immune system is critical for host defense. 
To maintain homeostasis, the immune system must ensure that commensal microbial load is 
tolerated while remains reactive to pathogenic microbial invasion. These communications are 
mediated by recognition of specific bacterial virulence factors with pattern recognition receptors 
expressed on host cells. While it has been shown that C. acnes clinical strains can induce a pro-
inflammatory response that strongly correlated with their clinical association (Yu, Champer et al. 
2016, Agak, Kao et al. 2018, Kolar, Tsai et al. 2019), these studies have not been able to 
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identify distinct virulence-associated bacterial components that can explain the distinct immune 
response of the different strains. Here, we identified that RNA species from CA can activate the 
immune response that are usually reserved for viral detection. Interestingly, CA and CH harbor 
different species of RNA that can trigger distinct immune response as seen with live bacteria.  
We were interested in IFN-γ given its role in both innate and adaptive immune response 
(Ivashkiv 2018). Our experiments suggest IFN-γ plays a role in bridging the innate and adaptive 
response in C. acnes infection given that it increased early and continued to rise throughout the 
72-hour (Fig. 2.1d). We identified NK cells to be the main producer of IFN-γ in vitro (Fig. 2.2d). 
TLR8 is a human a pattern recognition receptor (PRR) that can recognize RNA and activates 
pathways to cleave IL-18 and secrete IL-12p40 (Bergstrom, Aune et al. 2015, Coch, 
Hommertgen et al. 2019). Experiments with neutralizing antibodies and antagonist treatment 
showed that IL-12p40, IL-18, and TLR8 are required for IFN-γ secretion (Fig. 2.3b-d). These 
findings were also verified as clinically relevant with our scRNA-seq experiment. We found that 
more lesional cells express IFNG (Fig. 2.6a); however, these most of IFNG expression came 
from CTL in the lesion rather than CD56+ NK cells as we observed in PBMC in vitro (Fig. 2.2c). 
This could be due to the nature of the infection. Our time point for IFN-γ secretion is 24-hours to 
look for early immune activation of C. acnes. The acne lesions we sampled could be exhibiting 
the immune response a later time point with CTL secretion of IFN-γ. We also verified in the 
lesion that TLR8 expression was most distinct for lesional and non-lesional compared to TLR2 
and TLR4 (Fig. 2.3f). We also found IL18 is highly expressed in lesional macrophages (Fig. 2.6f, 
h). Both IL18 and TLR8 expression were most abundant in TREM2 macrophages (Fig. 2.6e, j). 
TREM2 macrophages were most similar to macrophages found in diseases characterized by 
alteration in lipid metabolism such as obesity and atherosclerosis (Keren-Shaul, Spinrad et al. 
2017, Lavin, Kobayashi et al. 2017, Cochain, Vafadarnejad et al. 2018, Jaitin, Adlung et al. 
2019, Wang, Dai et al. 2019, Xiong, Kuang et al. 2019, Xue, Tabib et al. 2020). In vitro data 
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suggests that differentiated TREM2+ macrophages had enhanced phagocytosis of C. acnes but 
no antimicrobial response against the bacteria. Instead TREM2+ macrophages upregulate 
processing of IL-18 to activate the immune response. Since in vitro data suggests TREM2+ 
macrophages have no antimicrobial activities, bacteria inside the macrophage could be 
releasing excess RNA species that activate TLR8. Macrophages then secrete IL-18 and IL-
12p40 to activate NK, CD8, CD4 T cells to secrete IFN-γ for immune cell activation promoting 
inflammation (Fig. 2.7).  
We also found that the ligand for IFN-γ induction required bacteria-host interaction 
because there was no cytokine secretion when PBMCs were stimulated with bacterial 
supernatant in a transwell experiment (Fig. 1.11b), where the cells are not able to directly 
interact with the bacteria. We hypothesized bacterial RNA as a possible ligand for IFN-γ 
induction when we found RNAse-treated host cells did not mount an immune response (Fig. 
2.4a). We further confirmed bacterial RNA role in inducing an IFN-γ response when we 
transfected CA and CH RNA with a liposomal transfection reagent, DOTAP. Secretion levels of 
IFN-γ, IL-18, and IL-12p40 were similar to the response to live bacteria in PBMCs and MDMs 
(Fig. 2.4c-g). Interestingly, we found CA to have high levels of short RNA (25-200nt) fragments 
and undetectable amount of 1000-4000 nt length corresponding to ribosomal RNA, differing 
from CH and other Cutibacterium spp (Fig. 2.5a-c). Nucleic acids, particular RNA, can act as a 
robust immune activator because detection of these RNA signifies that the microorganism 
encountered is metabolically active and potentially presents a greater threat than its dead 
counterpart. Immunologist has coined this phenomenon viability-associated pathogen-
associated molecular patterns (vita-PAMPs) (Underhill and Goodridge 2012). These RNAs are 
present only in viable bacteria and often reserved for pathogenic strains meant to elicit robust 
innate immune response. When macrophage phagocytose live bacteria, bacterial RNA may leak 
out of the phagolysosome and be detected by cytosolic receptors. In simpler terms, bacterial 
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RNA is used by the innate immune system as a proxy to identify pathogenic, viable bacteria 
(Underhill and Goodridge 2012). This could suggest why the transwell experiment did not result 
in the induction of IFN-γ secretion. The macrophages needed to phagocytose bacteria in order 
to activate the TLR-8 response. It would be interesting to sequence RNA from CA and CH and 
compare the sequences of each species of RNA.  
Taken together, our results showed that C. acnes RNA plays a role in modulating 
inflammation and that RNase has the ability to inhibit IFN-γ secretion. It would be interesting to 
test whether RNase can also inhibit other inflammatory cytokine caused by C. acnes infection.  
These results suggest that the CA RNA-based element may be key to how host cells distinguish 
CA versus CH. The identification of RNA as contributing to inflammation in C. acnes infection 
provides a potenteial target to develop novel therapeutics for acne vulgaris.  
 
Materials and Methods 
Healthy Blood donors, skin samples, and single cell library preparation 
The study was performed in accordance with protocols approved by the institutional 
review board at University of California, Los Angeles. All patients provided written informed 
consent. Healthy blood and acne donors were recruited from the University of California, Los 
Angeles. Patients were excluded from the study if they had been using acne medication, 
hormonal regulation medication, or hormonal-related implants in the past three months. Skin 
samples were obtained from 3mm punch biopsies in the back. Briefly, skin was digested 
enzymatically at 2 hours with 0.4% Dispase II at 37°C with agitation. The epidermis was 
separated from the dermis. Epidermis was then treated with 0.25% Trypsin and 10U/mL of 
DNAse I for 30 minutes. Dermis was homogenized and treated with 0.4% Collagenase II and 
10U/mL DNase I for 2 hours. Isolated cells were loaded into the Chromium instrument (10X 
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Genomics) according to manufacturer’s protocol and analyzed using Seurat (19, 20). Pseudo-
time trajectories for macrophage cluster were constructed using Monocle 2, an R package (45).  
Whole blood was obtained from healthy donors who provided written informed consent 
(UCLA Institutional Review Board). PBMCs were isolated by Ficoll-Paque (Sigma) density 
gradient centrifugation and cultured in RPMI 1640 (Gibco) supplemented with 10% fetal bovine 
serum (FBS) (Seradigm) at a density of 2.5x106/mL in a 24-well flat-bottomed plate.  
Macrophages were generated from CD14 positive cells isolated using CD14 microbeads 
(Miltenyi Biotec) according the manufacture protocol. CD14 positive cells were cultured with M-
CSF (50ng/mL) or GM-CSF (50ng/mL) in RPMI 1640 supplemented with 10% FBS for 5-6 days 
at a density of 5x105/mL in a 24-well plate.  
 
Reagents for Cell Stimulation. 
19kD, a TLR2/1L synthetic lipopeptide derived from the 19kDa mycobacterial lipoprotein 
was obtained from EMC Microcollections and used at 10 ug/ml. LPS E. coli (Sigma) was used at 
a concentration of 2 μg/ml. TL8-506 (TLR8 agonist) (Invivogen) were used according to 
manufacturer protocol. Tetanus toxoid (Invitrogen) was used at a concentration of 5 µg/mL. 
Total RNA was added at (5ug/mL) 
 
Bacteria.  
C. acnes were obtained from BEI resources and include HL005PA1, HL043PA1, 
HL096PA1, HL042PA3, HL110PA3, HL110PA4. Colonies were grown on brucella agar with 5% 
sheep blood, hemin, and vitamin K (Thermo Fisher Scientific Remel Products, Lenexa, KS) at 
37C for 5-7days under anaerobic conditions in sealed containers containing oxygen-absorbing 
carbon dioxide-generating Anaeropack (Mitsubishi Gas Chemical Co., Inc, Tokyo, Japan), 
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Cultures inoculated from single colonies were grown under the same conditions in Reinforced 
Clostridial Medium (Oxoid, Basingstoke, England).  
 
Bacterial treatment 
Live bacteria were heat-killed at 95˚C for 10 mins and cooled on ice before addition of 
bacteria to cell culture. Live bacteria were digested using RNase cocktail (Invitrogen) or DNase I 
(Invitrogen) and incubated at 37C for 1 hour. Nucleases were inactivated with 0.1% SDS.  
 
Bacterial total RNA extraction 
Total RNA from C. acnes pellets was extracted as described (Su, Chan et al. 2014, Hia, 
Chionh et al. 2015) using phenol:chloroform:isoamyl alcohol and sodium acetate pH 5.2. 
Aqueous phase was collected, and total RNA was precipitated with 1:1 isopropanol at -20C for 1 
hour. RNA pellet was washed with ethanol, air-dried, and resuspended in RNase-free water. 
RNA profiles were analyzed on RNA 6000 Nano chips using Agilent Bioanalyzer (Agilent 
Technologies) at the Technology Center for Genomics & Bioinformatics (TCGB) Core at UCLA. 
All RNA samples were used immediately or stored at -80C.  
 
Cytokine Quantification 
Cell culture supernatants were harvested at 24h unless otherwise noted. Cytokines 
measured by sandwich ELISA using antibody pairs were as follows: IL-18, IL-1β, IL-12p40 (R&D 
Duoset), IFN-γ (BD), IL-6, TNF-α (Invitrogen).  
 
Intracellular Flow Cytometry 
PBMCs were stimulated with CA for 19 hours and a protein transport inhibitor was added 
during the last 5 hours. Cells were stained with CD3 BV605, CD4 BV421, CD8 FITC, CD56 PE, 
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or IFN-γ-APC (Biolegend). Cells with were fixed using BD Perm/Fix Buffer (BD) according to 
manufacturer’s protocol. Data was acquired on BD LSRII analyzer. 
 
Statistical Analysis.   
Statistical analyses were calculated using GraphPad Prism version 8.0, and p values ≤ 
0.05 were assigned as significant. For comparisons involving two groups, a paired Student t test 
or one-way ANOVA with Sidak posttest was performed. For more than two comparison groups, 
a one-way ANOVA with Tukey posttest, a two-way ANOVA with Tukey posttest, or a Friedman 
test with Dunn posttest was performed. Data are represented in figures as mean ± SEM. 
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Fig. 2.1. CA infection induces IFN-γ secretion at an early time point 
 
(a-c) PBMCs were stimulated with C. acnes CA or CH at an MOI of 0.5. Various cytokines were 
measured at 24h via ELISA. (d) PBMCs were stimulated with C. acnes CA or CH at MOI 0.5 and 
tetanus at 5 µg/ml and various time points were collected from 3 hours to 7 days. N = 3 for each 
experiment. 
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Fig. 2.2. CA infection induces IFN-γ secretion at an early time point 
 
(a-b) CD3, CD56, and CD14 were depleted or isolated use magnetic microbeads (Miltenyi) were 
stimulated with C. acnes CA MOI 0.5. IFN-γ was measured at 24h via ELISA PBMCs were 
stimulated with CA for 19 hours and the last 5 hours was the presence of protein transport 
inhibitor. Cells were stained with CD3 BV605, CD4 BV421, CD8 FITC, CD56 PE, or IFN-γ-APC 
(Biolegend). Cells with were fixed using BD Perm/Fix Buffer (BD) according to manufacturer’s 
protocol. Data was acquired on BD LSRII analyzer. (c) An example traces of IFN-γ intracellular 
flow cytometry. (d) Summary with percentage of cells for n =3.  
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Fig. 2.3. TLR-8, IL-18, and IL-12p40 are required IFN-γ secretion  
 
(a) PBMCs were stimulated with C. acnes CA at MOI 0.5 for various time points were collected 
as listed from 3 hours to 24 hours. N = 3 for each experiment. (b) CD3, CD56, and CD14 were 
depleted or isolated use magnetic microbeads (Miltenyi) were stimulated with C. acnes CA MOI 
0.5. IFN-γ and IL-6 were measured at 24h by ELISA. n ≥3. 
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Fig. 2.4. CA RNA induces higher secretion of IFN-γ, IL12p40, and IL-18 compared to CH 
RNA similar to the live bacteria response 
 
(a) PBMCs were stimulated with untreated, heat-killed (HK), RNase cocktail, or DNase I treated 
live CA (HL5PA1) for 24h. (b) PBMCs were stimulated with live CA, CA bacteria-free supernatant 
(CA supe), CA RNA, CA DNA, or transwell. IFN-g was measured by ELISA at 24h. (C-E) PBMCs 
stimulated with live, total RNA (5μg/mL) with DOTAP from CA and CH. MDMs were stimulated 
with either live C. acnes or C. acnes total RNA (5μg/mL) for 24h. Cytokines were measured in 
the 24h supernatant by ELISA.  
82 
 
 
Fig. 2.5. CA and CH harbor different species of bacterial RNA 
Total RNA from various bacteria was isolated and loaded on to the Agilent Bioanalyzer using 
RNA 6000 Nano chip. 
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Fig. 2.6. In vivo scRNA-seq data from acne lesions confirms higher expression of TLR8, 
IL18, and IFNG 
Violin plots showing the normalized expression levels for IFNG in (a) all cell types lesional 
versus non-lesional (b) grouped by cell types (c) grouped by sub-clusters of lymphocytes. Violin 
plots showing normalized expression levels for IL18 in (d) all cell types lesional versus non-
lesional (e) grouped by sub-clusters of macrophages. Violin plots showing the normalized 
expression levels of (f) TLR2, TLR4, TLR8 in lesional and non-lesional cells (g) grouped by cell 
types (h) grouped by sub-clusters of macrophages. (i) Heatmap of z-scores calculated based on 
the expression of each cell type normalized across all samples for TLR8, IFNG and IL18. 
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Fig. 2.7. Proposed model of C. acnes infection with bacterial RNA stimulating TLR-8 
CA RNA can activate TLR-8 receptor on monocytes/macrophages to secrete IL-12p40 and IL-18 
to stimulate NK, CD8 T, and CD4 T cells. The cells secrete IFN-γ which can activate the 
immune response and promote inflammation.  
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CHAPTER 4 
 
Conclusions 
 
In this dissertation, we began with a hypothesis that changes in sebum production and 
the presence of distinct C. acnes phylotypes differentially trigger inflammation in lesions and in 
vitro. We performed scRNA-seq on lesional and non-lesional skin biopsies of acne individuals. 
We identified several interesting sub-clusters of cells that are specific to acne lesions. 
Keratinocytes in the hair follicle, localized by the expression of KRT6B and KRT6C, were found 
to contribute to the production of squalene in the hair follicle with the expression of FDFT1 and 
SQLE. As the first oxygenation step in cholesterol biosynthesis, SQLE is thought to be one of 
the rate-limiting enzymes in this pathway. The conversion from squalene to squalene epoxide is 
required for the lanosterol synthesis and eventually cholesterol (36). Since SQLE requires 
oxygen but the anerobic environment in pilosebaceous unit limits its function, the result is a 
buildup of squalene in sebaceous gland (2). Anaerobic environment is evident in the expression 
of HIF1A in the hair follicle KC sub-cluster. This suggest keratinocytes contribute to the 
production of squalene synthesis in the hair follicle. 
We also uncovered a subset of specialized TREM2 macrophages in acne lesions. These 
macrophages are similar to macrophages found in high lipid environment that are associated 
with disease of dysfunction lipid metabolism such as including obesity, atherosclerosis, lung 
cancer, and nonalcoholic fatty liver disease (Keren-Shaul, Spinrad et al. 2017, Lavin, Kobayashi 
et al. 2017, Cochain, Vafadarnejad et al. 2018, Jaitin, Adlung et al. 2019, Wang, Dai et al. 2019, 
Xiong, Kuang et al. 2019, Xue, Tabib et al. 2020). The uptake of lipids by macrophages is 
mediated by micropinocytosis and various cell surface receptors. Instead of limiting uptake of 
lipids, macrophages largely depend on cholesterol efflux pathways to maintain cellular lipid 
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homeostasis (Batista-Gonzalez, Vidal et al. 2019). TREM2 is a transmembrane glycoprotein 
that can interact with lipoproteins, phospholipids, and anionic ligands (Kober and Brett 2017) 
and can uptake lipids that binds to APOE (Yeh, Wang et al. 2016). ABCA1, the key efflux 
transporter of lipids, is upregulated in the activation of liver X receptor (LXR) (Costet, Luo et al. 
2000). We saw evidence of lipid processing in TREM2 macrophages with the increase 
expression of cathepsins (CTSB, CTSD), lysosomal acid lipase A (LIPA), acetyl-coA 
acetyltransferase 1 (ACAT1, gene SOAT1), intracellular lipid transporters such as Niemann-Pick 
disease (NPC1, NPC2) as well as a marker for intracellular storage of lipid droplets perilipin 2 
(PLIN2). Excess lipids activate LXRs (gene NR1H3) to upregulate ABCA1 as well as lipid carrier 
APOE to facilitate efflux. Macrophages mainly use ABCA1 to maintain a balance between 
uptake and export of lipids. For macrophages to upregulate lipid metabolism and efflux 
pathways suggest there is an active effort process lipid. This further suggests these 
macrophages are loaded with lipids. The presence of TREM2+ macrophages in acne lesions 
along with the finding that squalene, a lipid that is abundant in acne, induces and activates 
TREM2+ macrophages. This indicates that TREM2+ macrophages are part of the host 
inflammatory response to extracellular lipids.   
Squalene, a component that is unique to human sebum, induced the expression of 
TREM2 in macrophages in vitro. These macrophages expressed similar pattern of genes to 
TREM2 macrophage in acne lesions. We observed that their cytoplasm was filled with lipids 
validating our hypothesis of uptake of lipids. Foam cells, which have been found in acne lesions 
(Lovaszi, Mattii et al. 2017), happen when macrophages overloaded with lipids that they give a 
“foamy” appearance on histology. These differentiated TREM2+ macrophages had enhanced 
phagocytosis of C. acnes but no antimicrobial response against the bacteria. Squalene-treated 
TREM2+ macrophages IL-1β and IL-18 both are known to recruit neutrophils and recruit Th1 
response. These results indicate that excess lipid production, specifically squalene, could 
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initiate the inflammatory cascade by neutralizing the macrophage’s ability to kill bacteria, 
allowing for the bacterial escape, and activating the innate and adaptive immune response with 
the release of inflammatory cytokines.  
Our results underline   pivotal role for squalene in the initiation of inflammation in acne. 
Squalene is an unsaturated hydrocarbon and a precursor to cholesterol. While other tissue can 
rapidly convert squalene into cholesterol, human sebocytes accumulate sebum (Lovászi, 
Szegedi et al. 2017). It was initially thought of an inert lubricant of the skin. However, squalene 
can be neutralized with UV irradiation to induce reactive oxygen species in the skin and has 
been reported to induce comedone formation in the skin (Chiba, Yoshizawa et al. 2000). It was 
also reported that acne patients had higher levels and higher proportion of squalene on their 
skin compared to healthy controls (Pappas, Johnsen et al. 2009). Squalene represents an 
attractive therapeutic approach to prevent inflammation. A small molecule inhibitor, acetyl coA 
carboxylase inhibitor, to target sebum synthesis underwent a phase 3 trial to treat acne. 
However, the primary endpoint saw no reduction in inflammatory lesions. Interestingly, the small 
molecule inhibits all the other sebaceous lipid synthesis except for squalene and cholesterol 
(Bissonnette, Poulin et al. 2017). It would be interesting to investigate how squalene synthesis 
affect resident cells and other strains of C. acnes in the skin. 
In chapter 3, we investigated how different strains of CA versus CH differ in their 
inflammatory potential trigger inflammation in immune cells. Specifically, we looked for distinct 
virulence-associated bacterial components that could explain the distinct inflammatory potential 
of the different strains of C. acnes. Given the important role of IFN-γ in both innate and adaptive 
immune response (Ivashkiv 2018), we identified the source of IFN-γ to be NK cells in vitro and 
NK cells and CTL in acne lesions. The ability of C. acnes to induce IFN-γ was found to be 
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dependent on the TLR8-mediated release of IL12 and IL-18, a cytokine known to trigger the 
release of IFN--γ from lymphocytes.  
RNA was found to play an important role in IFN-γ induction. IFN-γ was elicited only by 
viable C. acnes and was abrogated after pretreatment with RNase but not DNase. Transfection 
of RNA with DOTAP elicited IFN-γ, IL-18, and IL-12p40 release from PBMCs and MDMs. The 
difference of cytokine release was similar to those with live bacteria where CA RNA elicit greater 
IFN-γ secretion than CH RNA. The RNA species also varied in sizes with CA harbored a short 
(25-200nt) RNA species while CH harbored both short RNA species and a long (1000-4000 nt) 
RNA species. 
Immune cells employ multiple ways to detect pathogenic invaders. A recent pathway 
was observed in macrophages to distinguish between live and dead E. coli through the 
detection of vita-PAMPs (Underhill and Goodridge 2012). When live bacteria are phagocytosed 
and degraded in the phagolysosome, they release RNA, which is thought to leak out into the 
cytoplasm. Cytosolic receptors can then detect released bacterial RNA. On the other hand, 
when dead bacteria are engulfed, their RNAs are rapidly degraded so no RNA is detected 
(Underhill and Goodridge 2012). This could explain why PBMCs required direct contact with CA 
for IFN-γ secretion. Myeloid cells would have to first encapsulate the bacteria in a lysosome 
before the RNA are released. We plan to sequence the short RNA fragments from both 
phylotype of bacteria to compare their differences. 
Our in vitro data demonstrating activation of TLR-8/IL-18/IFN-γ pathway was validated in 
acne lesions with increased IL18 and TLR8 expression on lesion specific TREM2 macrophages. 
TLR8 expression was most distinct for lesional and non-lesional compared to TLR2 and TLR4. 
We also found IL18 is highly expressed in lesional macrophages. Both IL18 and TLR8 
expression were most abundant in TREM2 macrophages. TREM2 macrophages in acne lesions 
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were most similar to macrophages found in diseases characterized by alteration in lipid 
metabolism such as obesity and atherosclerosis (Keren-Shaul, Spinrad et al. 2017, Lavin, 
Kobayashi et al. 2017, Cochain, Vafadarnejad et al. 2018, Jaitin, Adlung et al. 2019, Wang, Dai 
et al. 2019, Xiong, Kuang et al. 2019, Xue, Tabib et al. 2020). Since in vitro data suggests 
TREM2+ macrophages have no antimicrobial activities, bacteria inside the macrophage could 
be upregulating its virulence factor transcription leading to excess RNA in the environment that 
is causing the upregulation of TLR8. This excess RNA could be due to the proliferation and, 
thus a high turnover rate, of the pathogenic C. acnes. 
In conclusion, this dissertation describes several novel findings in the pathogenesis of 
acne vulgaris. The presence of TREM2 macrophages have often associate with inflammatory 
diseases. Here, we showed TREM2 macrophages could also be associated with an infectious 
disease, acne vulgaris, where the presence of TREM2 indicate a dysfunction of lipid 
metabolism. We have also identified that RNA species from CA can activate the immune 
response. The RNA recognition through TLR-8 are usually reserved for viral detection. The 
differences in CA and CH RNA species, which trigger distinct immune response as seen with live 
bacteria, suggest bacterial RNA could activate the immune response. This work not only 
advances our understanding of acne vulgaris but also skin immunology. Environment can play 
an important role in activating the immune response that has not been realized before. While we 
often categorize bacteria based on various PAMPs they may have based on the morphology, 
bacteria may employ different strategies to evade the immune system as well as host immune 
cells employing different strategies to detect bacteria that we may not have previously known.  
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